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SUMMARY
Murine macrophages synthesise nitric oxide (NO) from L-arginine, and the reaction 
is catalysed by NO synthases (NOS). Macrophages stimulated by interferon-y 
(IFN-y) and low dose of lipopolysaccharide (LPS) or a high concentration of LPS 
alone can produce large amounts of NO. Using a murine macrophage cell line, 
J774, we have investigated the signalling mechanisms for NO production.
Transient increases in cyclic adenosine monophosphate (cAMP) did not affect the 
production of NO. However, prolonged elevation of intracellular cAMP levels, 
using the p ro s ta g lan d in  E 2  and p h o sp h o d ieste rase  in h ib ito rs  
isobutylmethylxanthine or rolipram, was found to inhibit NO production. This 
inhibition did not occur at the level of gene transcription, but at the post 
transcriptional level.
Interferon-y and LPS treatment resulted in protein kinase C (PKC) activation and 
translocation into the plasma membrane, which correlated with NO production and 
NOS activity. The activation and the translocation of PKC was inhibited by lL-4, a 
physiological inhibitor of NO synthesis. lL-4 and the PKC inhibitor, Ro31-8220, 
inhibited the transcription of inducible NOS (iNOS) gene. lL-4 did not induce an 
elevation of cAMP levels in macrophages. These data suggest that lL-4 acts by 
inhibiting the activation of PKC, which is essential in the induction of iNOS gene 
transcription, but not via the induction of cAMP generation.
We also showed that pertussis toxin (Ptx) sensitive-G-proteins are not involved in 
the induction of iNOS expression in macrophages, and modification of G-proteins 
by Ptx and cholera toxin (Ctx) did not alter NO production in J774 cells. NO
production, stimulated by IFN-y and LPS, was not inhibited by Ctx, even although 
Ctx induced significant levels of intracellular cAMP.
Furthermore, since phospholipase A% (PLA2) inhibitors, such as 4-4-octadecyL4- 
oxobenzene butenoic acid, 4-bromophenacyl bromide and dexamethasone, have no 
effect on NO production by J774 cells, it is suggested that arachidonic acid 
metabolites and PLA2  are not involved in NO production in macrophages.
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CHAPTER 1
GENERAL INTRODUCTION
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1.1. THE MACROPHAGE
1.1.1. M acrophage biology:
The term "macrophage" was first used more than 100 years ago by E lle  
Metchnikoff in Messina, to describe the large mononuclear phagocytic cells he 
observed in tissues [Karnovsky, 1981]. Ontogenetically, macrophages originate in 
the yolk sac [Moore and Metcalf, 1970], but in adult man arise from the bone 
marrow [Furth, 1989]. They are found in lymphoid organs, the liver, lungs, 
gastrointestinal tract, central nervous system, serous cavities, bone, synovium and 
skin. Macrophages are the major differentiated cells of the mononuclear phagocyte 
system originating from monoblasts in the bone marrow. Having arrived at their 
target organs, monocytes differentiate into macrophages [Furth and Cohn, 1968]. 
In the absence of a local inflammation, the migration of monocytes from blood into 
different tissues appears to be a random process [Terr, 1994]. Differentiation of 
promonocytes to monocytes is induced by retinoic acids, hydroxy vitamin Dg, 
TGF-p and IFNs as physiological agents and phorbol esters experimentally 
[Reviewed by Eilers etal., 1995]. Many cytokines play a role in this differentiation 
process. These include macrophage colony-stimulating factor (M -CSF), 
granulocyte macrophage colony-stimulating factor (GM-CSF), IL-3 and factor 
increasing monocytopoiesis (FIM) [Waarde et al., 1977; Shum and Galsworthy, 
1982] [Reviewed by Auger and Ross, 1992].
Under light microscopy, macrophages are generally large, irregularly shaped cells 
measuring 25-50 pm in diameter, with cytoplasm containing fine granules and 
multiple large, azurophylic granules. Cytoplasmic vacuoles are often seen near* the 
cell periphery, indicating active pinocytosis. The nucleus of a macrophage is round 
or kidney-shape, and possess one or two nucleoli and finely dispersed nuclear 
chromatin [Reviewed by Auger and Ross, 1992].
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Electron microscopy shows an eccentric nucleus of variable shape, with chromatin 
disposed in fine clumps. Cytoplasm contains scattered strands of rough 
endoplasmic reticulum, and a well-developed Golgi complex in a juxtanuclear
1.1.2. Plasma membrane structure and receptors of the macrophage:
position. It has also large mitochondria, variable numbers of vesicles, vacuoles and 
pinocytic vesicles, and electron-dense, membrane bound lysosomes [Reviewed by 
Auger and Ross, 1992].
The macrophage surface is covered in ruffles and microvilli, and small surface 
blebs [Auger and Rose, 1992]. Mononuclear phagocytes bear at least 50 distinct 
types of surface receptors that are coupled to various second messengers. These 
receptors determine and control activities, such as growth, differentiation, 
activation, recognition of foreign antigens and cytokines, endocytosis, migration, 
and secretion. These receptors can be classified into several groups, such as Fc and 
complement receptors, cytokine receptors, lipoprotein receptors, advanced 
glycosylation end-products receptors, Lectin-like receptors, and adhesion receptors. 
There are at least 4 distinct Fc receptors, including a high affinity receptor for 
immunoglobulins of the IgG2 a isotype (Fcy2 aR) and a distinct receptor for 
immunoglobulins of the IgGi and IgG2b isotypes (FcyiR/FcY2bR) [Springer and 
Unkless, 1984].
In general, cytokine receptors can be classified into several distinct families, 
according to similarities of the extracellular amino acid sequences and intracellular 
signalling pathways [Miyajimaetal., 1992]:
25
11 Receptors without tyrosine kinase activity:
la) Type 1 cytokine receptors: (e.g. Haematopoietic growth factor receptors):
These include IL-2, IL-4, IL-5, IL-6 , IL-7, IL -12, GM-CSF, G-CSF, and Epo 
(Erythropoietin). These receptors have a conserved motif containing cysteine and 
tryptophan residues in their N tenninal portion. A typical sequence of Trp-Ser-X- 
Trp-Ser (W-S-X-W-S) is present in the C terminus.
The IL-2R possess three polypeptide chains, designated a , p, and y, and it is 
known that a heterodimer of p and y chains is responsible for IL-2 signal 
transduction [Takeshitaetal., 1992; Taniguchi and Minami, 1993]. It was reported 
that the cytosolic domain of the IL-2RP chain cytosolic domain has a binding site 
for the Src family nonreceptor tyrosine kinases [Minami et al., 1993]. The IL-2Ry 
chain is shown to interact with ÏL-4 and IL-7, and probably with IL-13 [reviewed 
by Kishimoto, 1994].
The IL-4 receptor is typically present at low levels on the cell surface (a few 
hundred to a few thousand molecules per cell) [Mosley et al., 1989]. The IL-4 
receptor is a high affinity receptor, and is expressed on a variety of cells including 
nonhaematopoietic cells such as fibroblasts, neuroblasts, kératinocytes, hepatocytes 
and stromal cells [Lowenthal et al., 1988a]. The murine and human IL-4Rs are 
about 50% identical at the amino acid levels and contain the common motif of 
cytokine receptors [Idzerda et al., 1990; Galizzi et al., 1990]. There are three kinds 
of IL-4 receptor reported, so far. The molecular mass of the membrane bound form 
of IL-4Ra chain is 140 kDa. It has been shown the y subunit of the IL-2 receptor 
interacts with IL-4R, and forms part of the membrane bound IL-4 receptor complex 
[reviewed by Kishimoto, 1994].
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The second type of IL-4 receptor lacks the cytoplasmic region, enabling it to 
internalise ligand, but not to induce downstream signalling in the cell. A mouse 
cDNA encoding a soluble extracellular domain of the IL-4R has also been isolated, 
and this soluble IL-4R is capable of binding IL-4 with high affinity, and is 
expressed in several cell lines and tissues, nevertheless, the physiological 
importance is not known [Mosley et al., 1989], although it might be a carrier 
protein for IL-4 in the serum [Fernandez-Botran and Vitetta, 1991]. Some of the 
soluble receptors, e.g., soluble IL-4R and TNFR, serve as inhibitors for their 
respective ligands, at least in vitro [Engelmann et al,. 1989; Mosley et al., 1989].
I
The IL-4 receptor on resting B cells is upregulated by LPS or IL-4 itself, and the 
IL-4R on resting T cells is increased by stimulation with ConA or IL-4 [Lowenthal 
et al., 1988b; Ohara and Paul, 1988].
lb) Type 2 receptors: (e.g. IFN-a/p and IFN-y receptors): If
IF N -a  and IFN-p are produced by virus infected cells, whereas, IFN-y is 
produced by activated T cells and natural killer (NK) cells [Weismann and Weber, 
1986]. IFN-a and IFN-p share a common receptor, but the IFN-y receptor is 
distinct [Aguet et al., 1984; Merlin et al., 1985]. IFN-y receptors are expressed 
only in limited numbers (2 0 0 -10,000 /cell), like other cytokine receptors, but they 
bind ligand with high affinity (Ka=2x 10^-2x10^0 M) [Gray et al., 1989]. The 
IFN-y receptor consists of two chains, a  and p (accessory factor -1, AP-1) [Soh et 
al., 1994]. IFN-y receptor a  chain has the ability to bind to IFN-y with high 
affinity. Nevertheless, The presence of IFN-yRp chain is required for down-stream 
signalling, such as the activation of signal transducing factor-IFN-y (STF-IFN-y) 
and the induction of interferon response factor-1 (IRF-1) [Cook et al., 1994; 
Hemmi et al., 1992]. The murine IFN-y receptor a  chain has serine rich 
polypeptides of 471 amino acids, with a predicted molecular mass of 52.5 kDa, and
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is synthesised with an additional 17 amino acid signal peptide. The extracellular 
domain has 228 aa. and the intracellular domain has 200 aa. that are separated by a 
single 23 or 21 aa. transmembrane domain. The intracellular domains of IFN-y 
receptors contain an unusually high content (20-25%) of serine and threonine 
residues [Gray et al., 1989].
Ic) Type 3 receptors: (e.g. TNF receptors, Fas, CD40, NGF binding protein):
Since TN F-a and TNF-p are structurally and functionally homologous proteins 
[Goedell et al., 1986], two distinct receptors of TNF of 55 and 75 kDa bind TNF-a 
and TNF-p equally well [Schall et al., 1990]. Although the relationship between 
TNFR and Fas is not yet clear, it is known that an anti-Fas antibody can mimic 
TNF function and induce apoptosis [Yonehara et al., 1989].
Id) Type 4 receptors: (e.g. Immunoglobulin like receptors, IL-IR):
IL-IR has higher affinity for IL-lp than for IL -la  in T cells. However, it shows 
higher affinity for IL -la  than for IL-ip in B cells. IL-IR has an Ig-like motif in the 
extracellular domain. [Reviewed by Miyajima et al., 1992]. The cytoplasmic 
domain of the human 80 kDa IL-IR contains a sequence Lys-Lys-Ser-Arg-Arg 
(429-433 aa.) resembling a PKC phosphorylation site [Sims et al., 1988].
2) Receptors with tyrosine kinase activity:
2a) Receptors of the tyrosine kinase family (e.g. M-CSF and stem cell factor, 
SCF):
These receptors are also called proto-oncogenes, because they relay mutative 
signals. The M-CSF receptor (M-CSFR) extracellular domain contains five Ig-like
I
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repeats, and the large cytoplasmic domain has a tyrosine kinase, having a highly 
homologous aa. sequence with platelet derived growth factor receptor (PDGFR).
2b) Receptors with nonreceptor tyrosine kinase activity: Although IL-2 is a member 
of type 1 receptors, Lck, which is a tyrosine kinase, is associated with IL-2Rpc 
(common) chain in the absence of IL-2 stimulation, and activated rapidly upon 
ligand binding to IL-2R [Hatakeyama et al., 1991; Horak et al., 1991]. There is 
clear evidence that type I and type IIIFN  systems interact with Jakl and Tyk2, and 
Jakl and Jak2, respectively [Reviewed by Darnell et al., 1994; Taniguchi, 1995].
LPS receptors; the best known LPS receptor is CD14, which is a 55 kD a 
phosphatidylinositol (Pl)-linked protein, and is present on monocytes and 
macrophages [reviewed by Lynn and Golenbock, 1992]. A soluble form of the 
protein also exists and can be found in human serum [Bazil et al., 1989]. There is a 
50 kDa protein secreted by hepatocytes, namely, lipopolysaccharide binding protein 
(LBP). It binds to LPS and increases the endotoxin effect and mediates cellular 
responses even at subthreshhold LPS concentrations via binding to CD 14 and 
increasing the binding affinity of LPS to CD 14 [Schumann, 1992]. An LPS 
resistant mutant (called LR-9) of the J774.1 cell line was isolated, recently, which 
has no CD 14 expression on the cell surface, but possess normal CD 14 inRNA 
levels. In these cells, low concentrations of LPS (1-10 ng/ml) induced TNF-a 
production and arachidonate metabolite release in normal J774.1 cells, but failed to 
induce TNF-a production and arachidonate metabolite release in the LR-9 mutant 
cells. Interestingly, high concentrations of LPS (100-1000 ng/ml) could 
successfully induce TNF-a production and arachidonate metabolite release in both 
cell lines, indicating other LPS induction pathways rather than the crucial CD14- 
mediated stimulation [Nishijima et al., 1994]. It has been suggested that LPS can be 
taken up by nonspecific pinocytosis by macrophages, and soluble LPS receptors in 
the cytosol or microtubules, such as p-tubulin and microtubule associated protein-2
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in the cytoskeleton [reviewed by Ding and Nathan, 1992] may be responsible for 
the response to high concentrations of LPS in the LR-9 mutant cell line.
The information about the cytosolic domains and their functions in intracellular 
signalling pathways of cytokines, especially IFNs and IL-4, and LPS receptors will 
be given below under the section "Signalling pathways in macrophage activation". 
Some of the macrophage receptors are shown in table 1.1.
"I;
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Table 1.1: Surface receptors of monocytes and macrophages:
Fc receptors
IgG l, IgG2 , IgGs, IgG4, IgA, IgE 
Complement receptors
C3b, C3bi, C5a, C lq 
Cytokine receptors
MIF, LIF, CF, MFF, IL-1, IL-2, IL-3, IL-4, IL-10, IL-13, TGF-p, 
IFN-a, IFN-p, IFN-y, Colony-stimulating factors 
(GM-CSF, M-CSF/CSFl)
Receptors for peptides and small molecules
H i, H2 , 5HT, 1,2,5-dihydroxy vitamin D3, N-formuIated 
peptides. Enkephalins/endorphins, substance P, Arg-vasopressin 
Hormone receptors
Insulin, Glucocorticosteroids, Angiotensin 
Transferrin and lactoferrin receptors 
Lipoprotein lipid receptors
Anionic low density lipoproteins, PGE2 , LTB4 , LTC4 , LTD4 , 
Apolipoproteins B and E 
Receptors for coagulants and anticoagulants
Fibrinogen/fibrin, Coagulation factor VII, al-Antithrombin, Heparin 
Fibronectin receptors 
Laminin receptors
Mannosyl. fucosvK galactosyl residue. AGE receptors 
a2-Macroglobulin-proteinase complex receptors 
Others
Cholinergic agonists, al-Adrenergic agonists, p2-Adrenergic agonists
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AGE, advanced glycosylation end-products; GM, granulocyte macrophage; CSF, 
colony stimulating factor; VLDL, very low density lipoprotein; PG, prostaglandin; 
LT, leukotriene; Ig, immunoglobulin; C, complement; MIF, macrophage inhibitory 
factor; MAF, macrophage activating factor; LIF, leukocyte migration inhibition 
factor; MFF, macrophage fusion factor; IL, interleukin; H, Histamine; 5HT, 5- 
hydroxytryptamine [Reviewed by Auger and Rose, 1992].
I
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1.1.3. Macrophage functions:
Macrophages play important roles in health and disease. These roles can be 
classified into at least 9 areas: The acute phase protein response, haematopoiesis, 
haemostasis, the destruction of micro-organisms, the disposal of damaged or
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Functional, morphological, and phenotypic heterogeneity of macrophages may 
reflect the local environment of the macrophages and involvement in various 
physiological or pathological processes. Macrophage nomenclature depends on 
their tissue distribution, like Kupffer cells in the liver, alveolar histiocytes in the 
lung or giant cells in the central nervous system. Macrophages in the immune 
system carry out many functions, such as phagocytosis and destruction of micro­
organisms, chemotaxis, through pseudopodia movements in response to chemical 
substances, antigen processing and presentation, secretion of substances including 
some cytokines and tumour cell control. Some important secretory and release 
products of macrophages are IFN a, IFNp, M-CSF, GM-CSF, G-CSF, TN Fa, 
IL-1, IL-6 , IL-8 , IL-12, TGFp, reactive oxygen intermediates (ROI), reactive 
nitrogen intermediates (RNI), PAF and cyclo-oxygenase products, such as PGE2 , 
prostacyclin and thromboxane [reviewed by Nathan, 1987; Auger and Ross, 1992].
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senescent cells, wound healing, tissue repair and remodelling, atherogenesis, they 
also play an important role in autoimmunity and central nervous system diseases
[Auger and Ross, 1992].
1.1.4. Macrophage activation:
The activation of macrophages is a very important step in cellular immunity, since
their secretory products can drive the responses of T cells and natural killer (NK) 
cells, and the phagocytosis and destruction of foreign particules, like micro­
organisms and parasites [reviewed by Auger and Ross, 1992]. Macrophage
F;.;
activation involves the enhancement and suppression of various genes encoding for 
proteins essential for biological functions. This process can be regulated by many 
cytokines some of which are listed in table 1.2 .
IFN-y acts on macrophages by using high affinity surface receptors [Arai et al., 
1990]. Treatment of macrophages with IFN-y induces a state which was termed 
"primed". Primed macrophages become cytolytic when pulsed with low levels of 
LPS (ng/ml). These cytolytic macrophages are termed "fully activated" [Adams and 
Hamilton, 1992]. The role of signalling mechanisms will be explored in section
1.3.
Bacterial endotoxin is generally accepted as a prototypic macrophage activator. 
LPS, complexed to the 60 kDa serum glycoprotein lipopolysaccharide binding 
protein (LBP), can bind to the 55 kDa membrane glycoprotein CD 14 and directly to 
the CD11/CD18 complex, which are expressed by monocytes and macrophages 
[Wright et al., 1990; Lynn and Golenbock, 1992].
In fully activated macrophages, cytotoxic effects are mainly dependent on two kinds 
of secretory products of activated macrophages; reactive oxygen intermediates 
(ROI), such as superoxide [Dradth and Karnovsky, 1975], hydrogen peroxide 
[Nathan and Root, 1977], hydroxyl radical [Weiss et al. 1977], and reactive 
nitrogen intermediates (RNI), such as NO, nitrite, and peroxynitrite [Stuehr and 
Marietta, 1985; reviewed by Beckman and Tsai, 1994].
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Table 1.2: Selected  
suppressive effects on
extracellu lar
macrophages:
ligands with activating or
Ligand Macrophage activation Macrophage suppression
Cytokines
IFNa •f +
IFNP +
IFNy 4-
TNFa + +
IL-1 +
IL-2 +
IL-4 + +
IL-6 +
IL-13 +
Colony-stimulating factors
CSF-1 -
GM-CSF +
Growth factors
TGFP - +
MCP-1 +
Other molecules
LPS -f +
mal-BSA + +
PGE2 +
Dexamethasone +
Serotonin +
adapted from Adams and Hamilton, 1992; 
+; positive effect, -; negative effect.
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Activated macrophages encountering micro-organisms may affect them in at least 
three ways. Firstly, the intracellular environment can be changed to one which is 
unsuitable for reproduction of micro-organisms. For instance, the intracellular pH 
may be decreased or nutrition factors may be denied to micro-organisms in the 
phagolysosome. Secondly, a killing reaction may be activated against dividing 
organisms. Thirdly, microbiostatic or microbicidal effector molecules like NO may 
be produced by activated macrophages. Therefore, some intracellular organisms are 
maintained in a non-replicating state.
1.2. NITRIC OXIDE
1.2.1. Historical review and the role of NO in organisms and the 
immune system :
NO has the lowest molecular weight of any known bioactive mammalian secretory 
product. Therefore, its diffusion in tissues is very fast, and interactions in 
signalling pathways in and between cells are possible. The first report came from 
Mitchell and colleagues in 1916 suggesting that mammals produce oxides of 
nitrogen [Mitchell et al., 1916]. Nevertheless, it was ignored until the 1980s. 
However, the existence of endogenous nitrite/nitrate synthesis in mammals was 
observed by some authors in the 1980s [Green, et al., 1981; Stuehr and Marietta,
1985]. Before 1987, NO had been known mainly as an atmospheric pollutant. 
Since then, NO synthases have been found in a very diverse range of other species 
from slime moulds through snails, horseshoe crabs, starfish, insects, chickens, 
mice, cows and humans [reviewed by Knowles, 1994]. Hibbs and colleagues 
reported the connection between L-arginine, L-citrulline and nitrite/nitrate release by 
activated macrophages [Hibbs et al., 1987a,b]. It was declared that NO is 
endothelial derived relaxing factor (EDRF) [Furchgott, 1988; Ignarro et al., 1987]. 
Moncada and co-workers demonstrated the widespread vasoregulatory effects of
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NO [Palmer et al., 1987, reviewed by Moncada et al., 1991]. Since then, progress 
in the biology of NO and signalling mechanisms has been increasingly fast. NO is a 
mediator for neurotransmission [Bredt and Snyder, 1992], penile erection [Rajfer et 
al., 1992; Burnett et al., 1992] and host defence mechanisms. In 1992, Billiar and 
colleagues showed that NO produced by activated macrophages may regulate the 
immune response [Billiar et al., 1992; Mills, 1991]. Until 1987, it was believed that 
activated macrophage cytotoxicity was due to the synthesis of reactive oxygen 
intermediates (ROI) by NADPH oxidase. Drapier and co-workers reported in 1991 
that using electron paramagnetic resonance spectroscopy, nitrosyl-iron complexes 
are present in tumour cells contiguous to NO-generating macrophages.
It is possible that NO is a paracrine effector molecule. A combination of NO with 
the superoxide anion in an acidic environment (e.g. in a phagosome), could yield 
toxic hydroxyl radicals [Mauel et al., 1992]. On the other hand, it was suggested 
that by reacting with the superoxide anion, NO may have a protective role in 
tissues, during inflammation [Billiar et al., 1992]. In addition, many authors 
suggested that NO production has potent cytotoxic effects for the facultative 
intracellular fungal pathogen Cryptococcus neoformans [Granger et al., 1988], 
schistosomula of Schistosoma mansoni [James and Glaven, 1989], intracellular 
amastigotes of Leishmania major [Green et al., 1990a,b; Liew et al., 1990a,b; 
Mauel et al., 1991], bacteria Francisella tularensis [Fortier et al., 1992] and 
mycobacteria [Adams et al. 1991] as well as intracellular trophozoites of 
Toxoplasma gondii [Adams et al., 1990]. Moreover, it was demonstrated by Liew 
and colleagues in 1990 that Leishmania major was killed directly by exposure to 
NO. Furthermore, it is important to consider other NO effects at the molecular 
level. Hibbs and co-workers showed in 1987 that the oxidation of L-arginine into 
nitrogen oxides is an effector mechanism causing target cell cytostasis as well as the 
reversible inhibition of the Krebs cycle enzyme aconitase by removal of its labile 
iron atom [Beinert and Kennedy, 1989] from the (4Fe-4S) cluster [Drapier and
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'■1IHibbs 1986]. Nitric oxide also leads to the loss of activity of complexes I and II of 
the electron transport chain in both macrophages and co-cultured tumour target 
cells [Drapier and Hibbs, 1988; Hibbs et al. 1988; Stuehr and Nathan, 1989]. It 
was reported that NO produced by peritoneal macrophages in response to IFN-y did 
not have killing activity on Brucellae abortus, since it does not possess iron- 
sulphur-containing enzymes that are tai’gets for NO [Jiang et al., 1993].
'Finally, NO can regulate the following processes in organisms: transcription factor
1.2.2. NO synthases isoenzymes and NO synthesis:
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activation; translation of mRNAs controlling Fe metabolism; mutagenesis;
apoptosis; glycolysis and mitochondrial electron transport; protein acylation;
-deoxynucleotide synthesis; fusion of myoblasts; adhesion of platelets and 
neutrophils; proliferation of myeloid progenitors; T cells, kératinocytes, and tumour
cells; release of pituitary hormones; the tone of bronchi and sphincters in the
.gastrointestinal system; the contractions of stomach, intestines, uterus, and heart;
'erection of the penis; opioid dependence; tolerance, and toxicity; memory; sleep; 
sunburn; and the pressure of the blood [Reviewed by Nathan and Xie, 1994].
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It has been shown that L-arginine is a precursor for nitrate biosynthesis in humans 
[Leaf et al., 1989]. Experiments with l^N-labelled arginine showed that both nitrite 
and nitrate were derived from the terminal guanidino nitrogen atom of this amino 
acid [Iyengar et al., 1987]. The oxidation products of L-arginine in m urine 
macrophages have been characterised to be L-citrulline and NO, which is rapidly 
converted into nitrite and nitrate in the presence of molecular oxygen [Marietta et 
al., 1988; Stuehr and Marietta, 1987]. It should be added that the half life of NO in
Ioxygenated media in vitro ranges from 5 to 50 seconds. Its half life in tissues is 
probably much shorter [Kelm and Schrader, 1990]. The enzymes, which catalyse 
the production of NO from L-arginine, are known as NO synthases (EC
1.14.13.39). In spite of the fact that the term NO is used for simplicity, the cells 
containing NOS possess a mixture of NO, NO2 , N 2 O 3 , NO2 ", NO3 ", 
nitrosamines, nonprotein nitrosothiols, and S-nitrosylated proteins [reviewed by 
Nathan, 1992].
Some analogues of L-arginine were reported as inhibitors of NO production in 
macrophages activated by IFN-y and LPS. These include N^-methyl-L-arginine (L- 
NMMA) [Iyengar et al., 1987], N-iminoethyl-L-ornithine (L-NIO) [McCall et al., 
1988], N<^-nitro~L-arginine methyl ester (L-NAME) and N^-nitro-L-arginine (L- 
NNA). L-NAME and L-NNA effects were fully reversible [Gross et al., 1990; 
McCall et al., 1991]. In addition, L-canavanine was shown to be an inhibitory 
effector molecule of the NO producing pathway [Iyengar et al., 1987].
Studies using ^^02 and mass spectrometry have shown that the inducible NOS 
(iNOS) incorporates molecular oxygen into both NO and citrulline in activated 
J774 cells [Leone et al., 1991]. It is clear that the inducible NOS, like the 
constitutive enzyme, can be classified as a dioxygenase.
Three distinct isoforms of NOS enzymes (more formally L-arginine, NADPH: 
oxidoreductase, NO-forming, EC 1.14.13.39) are accepted to be responsible for 
NO production from L-arginine and molecular oxygen. All of them have a 
consensus sequence for the binding of reduced nicotinamide adenine nucleotide 
phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin mononucleotide 
(FMN) and calmodulin and protein kinase A phosphorylation. The endothelial NOS 
{e NOS) also has an N-terminal consensus sequence for myristoylation [reviewed 
by Knowles, 1994]. Two of them, e NOS and neuronal NOS {n NOS), are 
constituvely expressed and calcium-dependent and generate low levels of NO, 
which are typically found in endothelial cells and neurones, respectively. The other 
is inducible by cytokines and/or microbial products like LPS [reviewed by
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Moncada et al., 1991] and generates high levels of NO. This isoform (iNOS) is not 
dependent on calcium concentrations in the physiological range, probably because 
calmodulin is tightly bound. The prototype of iNOS is found in macrophages that 
can be induced by cytokine treatment to 20 times its basal level. This induction 
takes several hours until maximal activity is reached, and cells produce nitrogen 
oxides over a period of several days [Stuehr and Marietta, 1987: Marietta et al, 
1988]. To date, NOS's have been purified from rat, pig, cow and man, rat, mouse 
and bovine cells [Reviewed by Nathan, 1992]. Some cell types may have both 
pathways [Kilbourn and Belloni, 1990], such as macrophages [Reviewed by 
Nathan and Xie, 1994]. The isoform purified and cloned from endothelial cells is 
also expressed in neurones [Dinerman et al, 1994]. The iNOS purified and cloned 
from macrophages is also expressed in neurones, endothelial cells, vascular smooth 
muscle cells and others [Oswald et al, 1994].
In general, the homology between equivalent isoforms from different species 
averages 90 ± 6  %, while within species, the homology between isoforms averages 
53 ± 2 % [Nathan and Xie, 1994].
The control mechanisms of iNOS synthesis may be at different levels of 
downstream signalling before the nucleus, at the transcriptional or post 
transcriptional levels. Ferric ions in the J774 macrophages inhibit iNOS 
transcription [Weiss et al., 1994]. Examples of post transcriptional control include 
TGF-p destabilization of iNOS mRNA in mouse macrophages. Cycloheximide 
stabilises iNOS mRNA in the vascular smooth muscle cells, while it prevents iNOS 
mRNA expression in mouse macrophages [Nathan and Xie, 1994]. The function of 
both types of NOS enzyme can be influenced by phosphorylation of their specific 
sequences for protein kinases, such as PKC, PKA and calcium-calmodulin- 
dependent protein kinases. It was shown that NOS purified from rat brain, which is 
Ca^+ and calmodulin-dependent, was phosphorylated by calcium calmodulin-
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dependent protein kinase II and PKC [Nakane et al., 1991]. iNOS displays a 
consensus site for phosphorylation by PKA located at a site different for the 
comparable sequence in cNOS. In both cNOS and iNOS this is a weak 
phosphorylation sequence, Lys-Arg-X-X-Ser, for PKA [Lowenstein et al., 1992]. 
Brune and Lapetina (1991) showed that PKA selectively and stoichiometrically 
phosphorlates NOS isolated from rat and porcine cerebellum. Table 1.3. shows the 
similarities and differences between the two isozymes of NOS.
1.2.3. Induction of NO production in macrophages:
The first observation about nitrate production came from rats treated with bacterial 
LPS; a nine-fold increase in nitrate excretion in their urine was observed [Wagner et 
al., 1983]. In vitro studies have also shown that murine macrophages treated with 
LPS produced nitrite and nitrate [Stuehr and Marietta, 1985]. IFN-y alone or in
combination with TN F-a, TNF-p or LPS leads to the formation of nitrite and 
nitrate in murine macrophage cultures and in a number of murine macrophage cell 
lines [Stuehr and Marietta, 1987]. Once iNOS is induced, NO may be released 
into tissues for days.
The mechanism which terminates high-output NO release has not been elucidated. 
However, there is evidence showing that NO itself can cause feedback inhibition 
[Assreuy et al., 1993]. The mechanism of this feedback inhibition is unknown at 
present.
It was reported that calcium ionophore A23187 could mimic the effects of IFN-y as 
a priming stimulus when applied together with LPS [Buchmuller-Rouyiller and 
Mauel, 1991]. Endogenously formed TNF-a and PGE2  are coinducers in rat 
Kupffer cells [Gaillard et al., 1991]. On the other hand, There are some cytokines.
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Table 1.3: S im ilarities and differences betw een the two NO
synthases:
Constitutive Inducible
Cytosolic* Cytosolic
NADPH dependent NADPH dependent
Dioxygenase Dioxygenase
Inhibited by L-arginine analogues Inhibited by L-arginine analogues
Ca^+/calmodulin dependent Ca^+/calmodulin independent
Pi comoles NO released Nanomoles NO released
Short-lasting release Long-lasting release
Unaffected by glucocorticoids Induction inhibited by glucocorticoids
(*: The e NOS enzyme has an N-terminal consensus sequence for myristoylation, 
and can anchor the plasma membrane)
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which were reported capable of blocking both NO synthesis and macrophage 
antimicrobial action. TGF-p, macrophage deactivating factor [Nelson et al., 1991; 
Nathan, 1992] and IL-4 [Liew et al., 1991] have inhibitory effects on N O  
production in macrophages stimulated by IFN-y and LPS. In addition, it was 
shown that glucocorticoids prevent induction of NOS in smooth muscle cells and 
macrophages [Rees et al., 1990; Knowles et al., 1990]. On the other hand, 
forskolin, an activator of adenylate cyclase, or dibutrylyl adenosine 3', 5'-cyclic 
monophosphate induces iNOS only modestly in vascular smooth muscle cells but 
synergistically induces iNOS when applied together with IFN-y, IL-1, or TNF in 
the same cells [Koide et al., 1993]. iNOS expression can also be inhibited by 
endogenous honnones such as corticosteroids, cortisol and corticosterone.
Exogenous application of the potent corticosteroid, dexamethasone, can almost 
completely inhibit iNOS expression in a number of cell types and reduces iNOS 
expression in hepatocytes [Geller et al., 1993]. The inhibitors of NO synthases are 
shown in table 1.4.
1.3. SIGNALLING PATHWAYS IN MACROPHAGE ACTIVATION:
In mutant cells lacking Jakl and Jak2 (non-receptor tyrosine kinases), the cells 
failed to respond to IFN-y. IFN-y treatment of cells resulted in the activation of p91
The binding of IFN-y to its receptor has been shown to produce at least one rapidly 
acting second messenger [Prpic et al., 1989]. Specifically, addition of IFN-y to 
macrophages causes a marked rise in intracellular pH accompanied by a 
concomitant influx of Na+ ions within seconds. This effect is inhibited by 
amiloride, suggesting that the exchange was mediated via the Na+/H+ exchanger or 
antiport [Smith et al., 1988].
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Table 1.4: Inhibitors of NOS's:
Class cNOS iNOS
Inhibitors of action
Substrate analogues N^-nitro-L-arginine 
N-iminoethyl-L-orni thine 
N^-methyl-L-arginine 
N^-amino-L-arginine 
N^-nitro-L-arginine methyl ester
N^-nitro-L-arginine
N^-methyl-L-arginine
N^-amino-L-arginine
Flavoprotein binders Diphenylene iodonium Diphenylene iodonium 
Di-2-thienyl iodonium
Calmodulin binders Calcineurin 
T rifluoroperazine 
N-(4-aminobutyl)- 
5-chloro-2-naphthalene- 
sulphonamide
None described
Heme binder Carbon monoxide Cai'bon monoxide
Depleter of 
tetrahydrobiopterin 2,4-Diamino-6-hydroxy-pyrimidine
Inhibitors of induction None described Corticosteroids
TGF-P i , 2, 3
IL-4
IL-10
IL-13
Macrophage 
deactivation factor
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protein, named cytokine activated transcription factor-1, signal transducers and 
activators of transcription (Statl), which is a component of IFN-stimulated gene 
factor-3 (ISGF-3) induced by IFN-a [Darnell et al., 1994]. The requirement of 
accessory factor (AF-1) for the induction of Statl activation has also been reported 
[Cook et al., 1994]. It was suggested that Jakl and Jak2 are associated with the 
IFN-yR, and Jakl and Tyk2 are associated with the IFN-aR. After the activation 
of these kinases Statl and Stat2 can be phosphorylated [Darnell et al., 1994]. The 
IFN-yR might be phosphorylated on tyrosine residues in response to IFN-y binding 
to its receptor, and Statl may bind to the phosphorylated IFN-yR [Darnell et al., 
1994]. On the other hand, the interferon-stimulated gene factor-3 (ISGF-3) 
formation, consists of Statl and Stat2, has been reported in response to IFN -a 
treatment of cells, leads to nuclear transcription activation, binding to the interferon- 
stimulated response element (ISRE) [reviewed by Darnel et al., 1994]. Other 
protein complexes induced by IFN-a treatment are ISGF-1 and ISGF-2 [David and 
Earner, 1992]. In monocytes (U937), instead of the tyrosine phosphorylation of 
Statl carried out by Jak kinases, serine phosphorylation has been found to be 
important for the elevated DNA-binding and transcriptional potential of IFN-y- 
activated transcription factor (GAF). In GAF activation, the Jak-dependent tyrosine 
phosphorylation and dimerization of Statl result in the potential binding of GAF to 
the IFN-y activation site (GAS) on the gene promoter [Eilers et al., 1995].
A variety of signals, including the lipopolysaccharide component of various 
bacterial cell walls, high concentrations of crude lymphokines, supernatants of 
tumour cells, heat-killed gram positive micro-organisms such as Listeria  
monocytogenes, and liposome-encapsulated muramyl di peptide, drive primed 
macrophages to the fully activated stage [Adams and Hamilton, 1984; Fidler,
1986]. Macrophages are a potent source of arachidonic acid metabolites. When 
macrophages interact with an appropriate stimulus, such as bacterial LPS, immune 
complexes, PM A, the Ca^+ ionophore A23187 and zymosan particles [reviewed
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by Aderem and Cohn, 1986], phospholipases are activated, resulting in the 
liberation of arachidonate from membrane phospholipids and its quantitative 
oxygenation via either the cyclooxygenase or lipoxygenase pathways. In 
macrophages, one of the major cyclooxygenase products synthesised is PGE2 
[Bonney et al. 1978, Scott et al. 1980].
One of the signalling pathway initiated by LPS in macrophages is the breakdown of 
polyphosphoinositides. Stimulation of macrophages with small concentrations of 
LPS (in the range of ng/ml) can result in the hydrolysis of phosphatidylinositol-4,5- 
bisphosphate (PIP2 ), the formation of inositol-1,4,5,-tris-phosphate (IP3 ), and 
tetra-/r/5- 1,3,4,5,-inositol phosphate (IP4 ) as well as the formation of 1,2- 
diacylglycerol (DAG) [Prpic et al., 1987]. LPS has been shown to produce a rapid 
and sustained elevation in Ca^+, dependent on an extracellular supply of calcium 
[Prpic et al., 1987]. In Raw 264.7 cells (murine macrophage cell line), LPS- 
induced NOS activity is dependent upon PKC, tyrosine kinase (TK) activities and 
endogenous poly-ADP ribosylation factors [Paul et al., 1993]. It also appears that 
the TK inhibitor, genistein inhibits iNOS activity and iNOS mRNA expression in 
J774 cells induced by IFN-y and LPS [A. Severn, personal communication]. 
Recently, it has been shown that LPS can provoke cellular responses by mimicking 
the action of ceramide [Wright and Kolesnick, 1995], which is a sphingolipid- 
derived intracellular messenger. However, LPS could not be substituted by 
ceramide in J774 cells [W.A. Sands, personal communication]. In myeloid cells, 
LPS, which has structural similarity to ceramide, has been shown to activate 
ceramide-activated protein kinase [Joseph et al., 1994]. It is suggested that TNF 
and IL-1 may mediate immune responses through ceramide generation [Kolesnick 
and Golde, 1994]. Treatment of cells with LPS results in nuclear factor kB  
activation (N F-kB ), as a result of phosphorylation of the inhibitor kB (IkB) 
[Muroi and Suzuki, 1993]. NF-kB exists in the cytoplasm associated with IkB,
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and the phosphorylation of NF-kB/IkB complex leads to release of the active NF- 
kB molecule [Henkel etal., 1993].
The cytoplasmic domain of the IL-4R contains 553 residues and is separated from 
the extracellular domain (137 residue) with the 24 residue transmembrane domain. 
The threonine at position 298 is potentially a protein kinase C phosphorylation site, 
which could play a role in receptor regulation and signal transduction [Edelman et 
al., 1987]. However, using a mutant hIL-4 receptor, it has been shown that amino 
acids in the cytoplasmic domain between positions 96 and 138 are important for 
signal transduction for the cell growth effect of IL-4 [Reviewed by Izuhara et al., 
1994b].
It has been shown by some authors that tyrosine kinases may interact with IL-4R, 
which could participate in the downstream signalling pathway in cells [Reviewed by 
Miyajima et al, 1992]. There is clear evidence that IL-4 treatment of HT2 cells 
results in protein tyrosine phosphorylation of 140, 110, 100 and 92 kDa proteins. 
The 92 kDa protein was recognised by anti-c-fes antibody, suggesting that c-fes 
proto-oncogene might be involved in the IL-4 signal transduction pathway [Izuhara 
et al., 1994a]. Moreover, the IL-4R cytosolic domain can be phosphorylated upon 
IL-4 stimulation [Izuhara et al., 1994b]. Results of studies by Izuhara and 
colleagues indicated that PI3 kinase is associated with the IL-4R, after IL-4 binds to 
its receptor. Involvement of PKC, cAMP elevation and Ca^+ influx in IL-4- 
mediated signalling in B cells have also been suggested [Finney et al., 1990]. It has 
been shown that PKCÇ isoform can be activated by phosphatidyl inositol kinase-3 
(PI-3 kinase) products, such as phosphatidylinositol 3,4,5-tris-phosphate (PIP3 ), 
and it can participate in the signal transduction of IL-4 [Nakanishi et al., 1993].
At the nuclear level, the effect of IL-4R activation results in the activation of a 100 
kDa cytosolic protein, called interleukin-4-induced transcription factor (IL-4 Stat or
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Stat-6 ), since the sequence of amino acids is similar to the Stat family [Wakao et 
al., 1994]. It was reported that the binding of IL-4 to IL-4R causes IL-4 Stat 
dimerization by the involvement of tyrosine phosphorylation at the C-termini [Hou 
et al., 1994], allowing them to leave the receptor and migrate to the nucleus [Hill 
and Treisman, 1995].
1.3.1. G-proteins and signal transduction;
G-protein-linked receptors are the largest family of celi-surface receptors. GTP is 
required for the activation of adenylate cyclase by |3-adrenergic agonists. Other 
known functions regulated by G-proteins are the inhibition or activation of adenylyl 
cyclase, the stimulation of retinal cGMP phosphodiesterases, the stimulation of 
phosphoinositide hydrolysis and the regulation of ion channels [reviewed by Hepler 
and Gilman, 1992; Houslay and Milligan, 1990], G-proteins can be subclassified 
into three main classes, as trimeric GTP-binding proteins, G-proteins which direct 
ribosomal protein synthesis, and monomeric GTP-binding proteins. Table 1.5. 
shows the classification and functions of trimeric G-proteins.
The binding of GTP causes activation of the G-protein and the hydrolysis of GTP 
initiates deactivation. It is clear that the a  subunit of the trimeric G-protein is not the 
only subunit active in cellular signalling, but the p/y subunits also play a role in 
some cells, such as cardiac atrial muscle (G§) and bovine rod outer segment cells 
(TD l) by activating phospholipase A% [Kim et al, 1989; Jelsema and Axelrod,
1987]. Meanwhile, in HL-60 cells, phospholipase C~p activity is stimulated by the 
G-protein p/y subunits [Camps et al, 1992]. Moreover, G-protein a  subunits, 
which are hydrophilic, can not be anchored to the phospholipid rich membrane 
without p/y subunits [Sternweis, 1986, 1993]. The p subunit alone is involved in 
coupling specific receptors to calcium channels [Kleus et al., 1992]. p/y subunits of 
Gi protein inhibit adenylyl cyclase activity by scavenging a  subunits from the
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Table 1.5; The structure and function of trimeric G-proteins;
G-protein Sensitivity to 
ADP-ribosylation 
by bacterial toxins
Function Distribution
Gs Y es. Cholera toxin Stimulation of adenylate 
cyclase, activation of 
dihydropyridine-sensitive 
Ca^+ channels
Universal
Golf Y es. Cholera toxin Stimulation of adenylate 
cyclase
Olfactory sen­
sory neurones
Gil Yes, Pertussis toxin Undefined Limited; high 
levels in brain
Gi2 Yes, Pertussis toxin Inhibition of adenylate 
cyclase, stimulation 
ofPLC
Universal
Gi3 Yes, Pertussis toxin Regulation of K+ channels Undefined;
Universal
Go Y es, Pertussis toxin Regulation of Ca^+ channels Limited
Gz No Undefined, stimulation 
ofPLC
Undefined, 
but restricted
TDl Yes, Cholera and Activation of cGMP Rod outer
and pertussis toxin phosphodiesterase segments
TD2 Yes, Cholera and Activation of cGMP Cone outer
pertussis toxin phosphodiesterase segments
Adapted from Milligan and Wakelam, 1989.
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cytosol and breaking the cycle of GTP-mediated activation. All trimeric G-proteins 
share other unique or unusual characteristics. For example, they are activated by 
AIF4 , because GDP-AIF4  mimics the effect of GTP [reviewed by Gilman, 1987]. 
In 1993, it has been reported that NO signalling in human peripheral blood 
mononuclear cells (PBMC) can regulate G-protein activity [Lander et al., 1993].
1.3.2. Cyclic nucleotides as second messengers:
If
Cyclic nucleotides are involved in the regulation of several macrophage functions, 
including phagocytosis, motility, responses to lymphokines, and DNA synthesis. 
Bromberg and Pick (1980) reported that macrophages treated with NO-generating 
agents showed an increase in cyclic GMP levels. Cyclic GMP is generated from 
GTP in response to the activity of guanylyl cyclase. NO generated in the 
macrophage cytosol stimulates soluble guanylate cyclase and results in cGMP 
elevation in several cells, such as vascular endothelial and smooth muscle cells 
present in the vascular wall [Mulsch et al., 1990].
The activation of adenylyl cyclase results in the formation of cAMP from ATP. In 
general, the a  subunit of Gs activates adenylyl cyclase. However, type II and IV 
adenylyl cyclases have been shown to be stimulated by G-protein p/y subunits in 
the presence of as subunit, and type III adenylyl cyclase has very little sensitivity to 
p/y subunits [Tang and Gilman, 1992].
Gene regulatory effects of cAMP are well established in eukaryotes [Roesler et al., 
1988; Karin, 1989]. The PKA enzyme can activate the cAMP response element- 
binding protein (CREB) [reviewed by Hill and Treism an, 1995] by 
phosphorylating it at Ser-133 amino acid point, then leads to the association of 
CREB with other cofactors, like cAMP receptor protein (CRP), for transcriptional 
activation. The CREB can be activated by calmodulin kinase and neurone growth
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factor, independently. The attenuation of the CREB effect can be caused by the 
inducible cAMP early repressor (ICER), which competes with CREBs to bind the 
cAMP-regulated enhancer (CRE) target sites on the gene promoter [Molina et al., 
1993].
1.3.3. Phospholîpases as generators of second messengers:
The phospholipids, which are substrates for phospholipases, can be divided into 
two main groups: the glycerophospholipids and the sphingophospholipids. 
Glycerophosphoiipids have either acyl (ester linkage) or alkyl (ether linkage) 
groups at the C(l) hydroxyl of the glycerol backbone and predominantly acyl 
groups at the C(2) hydroxyl. A hydrophilic phosphate at the C(3) position gives 
phospholipids the amphipathic character that is important for the formation of lipid 
bilayers and also provides a site for phosphodiester linkage to a variety of head 
groups, including choline, serine, ethanolamine and inositol. Phospholipids can be 
hydrolysed to generate a variety of potential second messengers by phospholipases 
that are classified on the basis of where the phospholipid is hydrolysed. 
Phospholipases A (PLA) hydrolyse ester linkages between the acyl group and the 
glycerol backbone at C(l) for PLAi or C(2) for PLA2 . The products of PLAs are a 
fatty acid and a lyso-phosphatidyl derivative. Phospholipases C (PLC) hydrolyse 
the phosphodiester linkage between the glycerol backbone and the phosphate to 
generate a diacylglycerol (DAG) and a phosphorylated head group. Phospholipases 
D (PLD) hydrolyse the phosphodiester linkage between the phosphate and the head 
group to generate phosphatidic acid (PA) and the head group. [Reviewed by Foster, 
1993]. Sites of hydrolysis of phospholipids by various phospholipases are shown 
in figure 1.1. ■I
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1.3.4, Sphingolipids as second messengers:
Sphingolipids play roles in many biological processes, such as cell-cell interaction, 
proliferation, differentiation, oncogenic transformation, immune recognition and 
responsiveness, and serve as receptors for microbial membrane lectins and viral, 
bacterial toxins [reviewed by Ballou, 1992]. So far, over 300 types of 
sphingolipids have been reported. Sphingolipids are derived from ceramide. 
Sphingomyelin has a phosphocholine head group attached to ceramide via a 
phosphodiester bond [van Holde, 1992]. The PKC inhibition has been reported in 
response to sphingosine, but not to ceramide [Hannun etal., 1986].
The enzyme, sphingomyelinase, hydrolyses sphingomyelin to produce ceramide 
and phosphorylcholine [Merril and Jones, 1990]. Ceramide and sphingosine induce 
PGE2  synthesis, adenylate cyclase activation and cAMP elevation in macrophages 
[reviewed by Ballou, 1992].
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Adapted from Bon ventre, 1992.
Figure 1 .1 : Site of hydrolysis of phospholip ids by various  
phospholipases:
P L A i hydrolyses the 1-acyl ester; PLA2 , the 2-acyl ester. Phospholipase B 
hydrolyses at the both 1- and 2- acyl ester bonds. Phospholipase C cleaves the 
glycerol-phosphate bond, whereas the base is removed by phospholipase D. R i 
and R2  represent fatty acids.
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1.3.5. Protein-serine/threonine kinases and intracellular signalling:
Phosphorylation of proteins at serine and threonine residues is one of the most 
frequent forms of post-translational modification leading to changes in biological 
function.
Protein-serine/threonine kinases can be classified into four main groups:
1) cyclic nucleotide-dependent protein kinases, i.e. cAMP-dependent and 
cGMP-dependent protein kinases (respectively PKA and PKG).
2) Ca^+-dependent protein kinases, such as phosphorylase kinase C, 
myosin light chain kinase and other calmodulin-dependent protein kinases, and the 
conventional protein kinase C family (cPKC)
3) messenger-independent protein kinases; many enzymes are in this group, 
including casein kinases I and II, glycogen synthase kinase-3, ribosomal protein S6 
kinases, and p-adrenergic receptor kinases.
4) Others; mitogen activated protein kinases (MAPK), the novel PKC 
(nPKC) and the atypical PKC families.
All these protein kinases can use ATP as the phosphoryl donor. A few of them can 
also utilise GTP, for example casein kinase II and glycogen synthase kinase-3 
[Reviewed by Wang and Roach, 1993].
1.3.5.1. Cyclic AMP-dependent protein kinases (PKA):
The PKA enzyme is composed of two regulatory (R) and two catalytic (C) subunits 
that together constitute an inactive holoenzyme of form R2 C2 . Binding of cAMP to 
the regulatory subunit dimer results in release and concomitant activation of the 
catalytic subunits. The hypothesis has been advanced that eukaryotic R subunits 
after binding of cAMP might directly function as transcriptional regulators 
[Nagamine and Reich, 1985; Constantinou et al., 1985]. On the other hand, it has
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been speculated that transcriptional regulation of eukaryotic cAMP-responsive 
genes may depend on the phosphorylation of trans-acting gene regulatory proteins 
by the C subunit of the kinase [Jungmann and Kranias, 1976; Johnson, 1982]. 
Moreover, previous studies have shown that increased intracellular cAMP levels 
can block receptor-induced PKC activation [Takai et ai., 1982a; Nishizuka, 
1984a,b; Coggeshal and Cambier, 1984; Patel et al., 1987].
1.3.5.2. Protein Kinase C:
Protein kinase Cs (PKCs) are phospholipid-dependent serine/threonine kinases. 
They can be divided into three main groups: the Ca^ "*"- and phospholipid-dependent
9 -4-or conventional PKCs (cPKCs), a, pi, pll and y isoforms, Ca -independent or
novel PKCs (nPKC), ô, e, t) and 0 isoforms, and Ca - and DAG-independent
atypical PKCs (aPKCs), and i (also called X in the mouse) [reviewed by Hug
and Sarre, 1993; Stabel and Parker, 1991; Limatola et al., 1994]. The foimer two
classes of protein kinase C are activated by DAG. Phorbol esters dramatically
9 -4-increase the affinity of cPKCs for Ca , resulting in its full activation at
9 -4-physiological Ca concentrations [Castagna et al., 1982; Fujiki et al., 1984]. 
cPKCs are "Biochemically'Vcalcium-dependent, but "physiologically"/ calcium- 
independent [Nishizuka, 1986; Kikkawa et al., 1983]. Atypical PKCs are resistant 
to even phorbol ester treatment [Limatola et al., 1994; Ways et al., 1992]. PKC-^ 
can be activated by phosphatidylinositol 3,4,5-tris-phosphate (PIP3 ) [Nakanishi et 
al,, 1993]. Phosphatidic acid (PA), bisPA and various other acidic lipids, such as 
phosphatidylserine (PS), lysoPA, PI, phosphatidyl glycerol (PG) and cardiolipin 
(CL), have been reported as physiological activators of PKC-Ç in the absence of 
Ca^+ [Limatola et al., 1994]. Interestingly, it was reported that m ilim olar 
concentrations of Ca^+ inhibit PKC-e and ^ [Schaap and Parker, 1990; Nakanishi 
and Exton, 1992; Limatola et al., 1994]. It was suggested that PKC-^ is not 
translocated to the membrane and is not affected by phorbol esters [Schaap and
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Parker, 1990]. The PKC-i isoform has 72 % homology with PKC-^. Like PKC-^, 
it has no Ca^+ binding domain (C2), and contains only one zinc-finger [Selbie et 
al., 1993]. The PKC-|x isoform has 44-68 % aa. homology with other PKC
isoforms, and contains two zinc-fingers (Cl) [Johannes et al, 1994].
Of the various phospholipids tested, phosphatidyl serine appears to be indispensable 
for the activation of PKCs, whereas other phospholipids may show either positive 
or negative cooperativity [Kaibuchi, et al., 1981]. It is possible that PKC might be 
activated in the absence of inositol phospholipid turnover. Some hormones and 
growth factor can stimulate phosphatidylcholine hydrolysis through the activation 
of PLC or PLD. DAG can be generated either directly by PLC or indirectly by PLD 
to yield phosphatidic acid, which is then hydrolysed to DAG [Reviewed by Pfeffer 
and Tan, 1991]. For instance, IFN-y rapidly activates PC turnover, which results in 
DAG production in HeLa cells [Pfeffer et al., 1990]. Regulation o f  
phosphorylation of 6 8  kDa protein by PKC in response to LPS in peritoneal 
macrophages has been observed [Rosen et al., 1989]. There are many controversial 
findings about PKC isoforms and their activation which require to be clarified.
The structures of PKCs may explain their different biochemical properties and 
functions. Figure 1.2. shows the regulatory and catalytic domains and molecular 
masses of 9 isoforms of PKC. PKC isozymes, excluding C and l  isoform s, 
contain a cysteine rich C l domain (DAG/phorbol ester binding site), which has two 
zinc motifs each with 6  cysteine residues. Nevertheless, the ^ and t isoforms 
contain only one zinc finger, which is probably the reason for the constitutive 
protein kinase activity exhibited by this isoform. PKC a , j3I/|3II, and y isozymes 
contain the Ca^"^ binding site (C2). The V3 variable chain (hinge region) separates 
the catalytic and the regulatory domains, and is sensitive to proteolytic cleavage by 
trypsin or the Ca^+-dependent neutral proteases, calpain I and II. The C3 region 
(ATP-binding site) is found in all isoforms, and is necessary for the
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Figure 1.2: Domain structure of PKC isoenzymes;
(Adapted from Hug and Sarre, 1993; Nishizuka, 1992)
V: Variable region, C: Conserved domain.
Cl: Cystein-rich zinc fingers (DAG/Phorbol ester binding site)
The ^  isoform contains only one zinc finger 
C2: Ca^+ binding site
V3: Hinge region separates the catalytic and the regulatory domains
C3: ATP-binding site
V4: Region separates C3 and C4 domains
C4: Substrate binding site/phosphate transfer region)
VO: PKC Ô, 8, ^ and r\ isoforms isozymes contain, but not PKC a, j3I/pII, and y 
isozymes.
V5: poorly conserved
fI
i
57
■
VI Cl 0 2 0 3 C4 V5
DDDDD□□□
Molecular Mass 
(kDa)
a
pi/pII 
Y
77-84
VO
ô 74-79
1 1 £ 89-96
,1 C1 82-86
Z
0 79
67
76-80
Regulatory Domain Catalytic Domain
58
I
phosphorylation of substrates. The V4 region separates C3 and C4 domains, and is 
present in all isoforms. The C4 region (substrate binding site/phosphate transfer 
region) is also present in all isoforms and is highly conserved. Additionally, PKC 
Ô, e, ^ and y] isoforms contain a VO, domain which is absent in a , pi/piI, and y 
isozymes. The V5 extension is poorly conserved.
1.3.6. Protein-tyrosine kinases:
PKC has a broad substrate specificity, phosphorylating seryl and threonyl residues, 
but not tyros y I residues, of many endogenous proteins in most tissues in vitro 
[Nishizuka, 1980; Takai et al., 1982b; Nishizuka et al., 1984b]. The consensus 
sequence for the phosphorylation site for PKC is xRxxS/TxRx found in the 
substrates [Rewieved by Hug and Sarre, 1993].
It was reported that inhibition of PKC activity, or down-regulation of PKC by 
prolonged incubation of cells with phorbol esters, reduces NO production in 
response to IFN-y and LPS [Severn et al., 1992b]. Furthermore, stimulation of 
macrophages with these agents results in translocation of PKC to the cell membrane
i-
[Severn et al., 1992b]. It was shown that J774 cells constitutively express PKC 
pil, 8, and Ç specific mRNAs and their translational products, but PKCa, y, and 
Ô specific mRNAs as well as their translation products were not detectable, and :
down-regulation of PKC pll, e, and Ç by using PMA pre-treatment resulted in 
reduced NO production and iNOS gene transcription in response to LPS in J774 
cells [Fujihara et al., 1994]. These observations suggest that PKC activation is 
essential in the induction of NO production by IFN-y and LPS. i
a ? t
Stimulation of cells by IL-2, IL-3, IL-4, IL-5, IL-6 , IL-7, GM-CSF, and Epo has 
been shown to activate intracellular tyrosine kinases and induce the tyrosine-specific 
phosphorylation of cellular proteins [Taga et al., 1992; Ip et al., 1992; Otani et al.,
1992; Kanakura et al., 1990; Nakajima and Wall, 1991; Linnekin et a l ,  1992].
PTKs transduce intracellular signals that lead to cell division. However, PTK
t
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activity does not always produce cell division signals [Reviewed by Foster, 1993].
It was reported by Foster and co-workers that PTKs (v-Src) may activate three 
distinct intracellular signalling mechanisms, namely, serine/threonine-protein 
kinases, Raf-1 and PKC, by using gene expression as an output signal for the PTK 
activity [Foster, 1993]. PTKs can be divided into two main groups, namely 
receptor tyrosine kinases and non-receptor tyrosine kinases. The binding of ligand 
to the extracellular domain activates the tyrosine kinase in the cytoplasmic domain, 
which leads to downstream activation of a number of common signalling 
molecules. Some intracellular proteins, such as PLC-y, phosphatidylinositol 3- 
kinase (PI3-kinase), GTPase-activating protein, pp60c-src, p21Ras, Raf-1 kinase,
ERKl and ERK2 (referred as MAP kinases) kinases, and S6  ribosomal kinases, 
are activated by the cytoplasmic domain of receptor PTKs [Fantl et al., 1993].
Since PTKs are not the subject of this project, the only nomenclature of PTKs is 
shown in table 1.6 .
.9
1.4. INTERACTIONS BETWEEN SECOND MESSENGER  
SYSTEMS:
1
Several of the second messenger systems have been shown to interact with one 
another. It is known that IFN-y and low concentration of LPS can synergise their 
many effects on macrophages [Green et al., 1990b]. First, IFN-y has been shown 
to cause PKC activation. When macrophages were stimulated by LPS or PAF or 
PMA after pre-treatment with IFN-y, phosphorylation of some target proteins was 
potentiated [Hamilton et al., 1985; Becton et al., 1985]. Secondly, IFN-y 
potentiates DAG generation [Sebaldt et al., 1990]. As a result of these changes, 
pre-treatment of macrophages with IFN-y potentiates the activation of Na+/H+ 
exchange induced by either LPS or PAF by making the shift of the intracellular pH 
into the alkaline more rapid and by raising the degree of alkalinization [Prpic et al.,
1989].
is.
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Table 1.6; Nomenclature of protein tyrosine kinases:
Receptor tyrosine kinases
i) The epidermal growth factor receptor family:
-Endothélia growth factor receptor (EGFR)
-pl85neu (erbB-2 or Hei^) -erbB-3
ii) The insulin receptor family:
-insulin-like growth factor receptor -insulin-related receptor
iii) The PDGF/MCSF-1/Steel receptor family:
-platelet-derived growth factor (PDGF) a-and  p receptor 
-the macrophage colony stimulating factor-1 (MCSF-1) receptor 
-c-kit protein
iv) The vascular Endothelial Cell Growth Factor Receptor Family
v) The Hepatocyte Growth Factor Receptor:
vi) The neurotrophin receptor family:
-Nerve growth factor (NGF)
-Brain-derived neurotrophic factor (BDNF)
-neurotrophin-3 (NT-3) -neurotrophin-4 (NT-4)
-neurotrophin-5 (NT-5)
vii) The fibroblast growth factor receptor family:
-acidic and basic FGF -the product of the int-2 oncogene
-the product of the hst oncogene -FGF5 -FGF6
-Keratinocyte growth factor (KGF)
viii) The Eph-Like Receptor Tyrosine Kinases:
-Eph -Eck -Elk -Eek -Erk -Cek4 -Cek5
I
ix) The Axl Receptor Tyrosine Kinase 
 
to be continued
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2) Non-receptor tyrosine kinases:
-Abl, Arg -Janus family, Jakl, Jak2, Jak3 -Tyk2 
-Fak -Fes/Fps, Fer -Spleen tyrosine kinase (Syk) and Zap
-Interleukin-2 inducible kinase (Itk/Tsk)
-B cell progenitor kinase (Bpk/Atk) -Tec kinase
: .-Src gene family, Src, Y es, Fyn, Lyn, Lck, Blk, Hck, Fgr and Y rk tyrosine 
-Csk kinase
%
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a
PG E 2 , is a potent suppressor agent of macrophage function, and can lead to 
elevated levels of cAMP. It has been found that at least one effect of cAMP is to 
suppress the activation of Na+/H+exchange in macrophages [Cowlen et al.,
1990].
1.5. CYTOKINES, NITRIC OXIDE AND IMMUNE REGULATION:
63
The signal transduction mechanisms initiated by EcyZaR and FcYlR/Foy2bR remain 
to be fully clarified. Activation of Foy2aR has been reported to raise intracellular
levels of cAMP approximately 5-fold within 30 s in the P388D1 macrophage cell 
line, while activation of the FoylR/FcY2 bR on this cell line leads to enhanced
release of arachidonic acid. Suzuki and colleagues (1982) have isolated from the 
same cell line phosphatidylcholine (PC)-binding proteins, which also bind 
immunoglobulins of the IgG2 b isotype and which have phospholipase A2  activity 
[reviewed by Nitta et al, 1984]. Additionally, the activation of Fc receptors can 
stimulate protein kinase C [Johnston, 1984].
As described above, PGE2 , acting via elevations in AMP can dampen responses to 
both IFN-y and to LPS by suppressing activation of Na+/H+ exchange [Figueiredo 
et al., 1990]. It has been found that LPS may block the PGE2 -m ed ia ted  
enhancement of cAMP activities possibly by activating PDEs that accelerate 
degradation of cAMP [Okonogi et al., 1991]. In many cells, the SH2-containing 
proteins, PI3 kinase and PLC-y interact with TK, and are activated [Reviewed by 
Foster, 1993].
Th 1-like cells produce lymphotoxin (LT), IL-2 and IFN-y, mediate cell-mediated 
immune responses important for the response to various infectious diseases, 
whereas Th2-like cells secrete IL-4, IL-5, IL-10 and IL-13, which are the 
predominant helpers of B cell responses, and are clearly implicated in allergic I
responses [Mosmann and Coffman, 1989]. IFN-y and LT activate macrophages 
and increases expression of Fc receptors for IgG2a antibodies [Warren and Vogel, 
1985]. These receptors can then bind the increased IgG2a levels produced in 
response to IFN-y [Snapper and Paul, 1987], leading to increased antibody- 
dependent macrophage cytotoxicity. Purified protein derivatives (PPD), prepared 
from tubercle bacillus, in the presence of IL-4 have been shown to stimulate Th2 
development from peripheral blood human T cells [reviewed by O'Garra and 
Murphy, 1995]. IFN-y has been shown to inhibit Th2 clones' proliferative 
response to either IL-2 or IL-4 [Fernandez-Botran et al., 1988; Gajewski and Fitch, 
1988]. IL-1, TGF-p and TNF-a are other cofactors for the production of T hl cells 
[H siehetal., 1993].
IL-2 induces macrophages to produce TGF-p, and then TGF-p can inhibit T cell 
proliferation, NO and PGE2  production, and microbicidal activity of macrophages. 
This inhibitory effect of TGF-p can be reversed by IFN-y and TNF-a [Reviewed 
by Doherty, 1995]. IL-10 inhibits a number of different macrophage activities, 
including cytokine production, such as IL-1, IL-6  and TNF-a [Bogdan et al., 
1991; Fiorentino et al., 1991], respiratory burst [Bogdan et al., 1991], la 
expression in monocytes [Malefyt et al., 1991], and NO production by 
macrophages induced by IFN-y and TNF-a [Oswald et al., 1992].
IL -12 was clearly identified as an inducer of the differentiation of Thl-like cells 
producing IFN-y [reviewed by Wolf et al., 1994]. IL-12 is a 75 kDa heterodimer, 
composed of 40 kDa and 35 kDa glycoproteins, secreted by phagocytic cells 
[D'Andrea et al., 1992; reviewed by Reiner and Seder, 1995], having multiple 
activities on natural killer (NK) cells and T cells [reviewed by Wolf et al., 1994]. In 
vivo T hl differentiation has been shown to be enhanced by IL-12. However, IL-12 
needs to work with IFN-y in Thl development, as a co-stimulator.
I
64
IL-13 affects macrophages but not T cells, then it can be accepted as macrophage- 
specific regulator without altering T cell functions [reviewed by Doherty, 1995]. 
Recently, it has been shown that IFN-y induces IL-15, a novel cytokine which has 
similar properties to IL-2, produced by macrophages [Reviewed by Doherty, 
1995]. The functions of IL-15 are yet to be investigated.
There are several diseases related to disturbances in Thl/Th2 ratios. For instance, in 
a helminthic disease, Nippostrongylus brasiliensis, high IgE levels, eosinophilia, 
high IL-4, IL-5 levels and low IL-2, and IFN-y levels indicate a Th2 dominant
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response. Interestingly, Leishmania infection shows different patterns dependent 
on the mice strains. BALB/c mice suffer from fatal, progressive disease and can not 
develop a Thl-dominant response. In contrast, C57BL/6 mice produce a very
'effective Thl-mediated response, with low levels of IL-4 and IgE and high IFN-y, 
and develop only a limited disease which heals spontaneously [reviewed by 
Mosmann and Coffman, 1989].
I
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Recently, the regulation of T cell functions by NO was reviewed by Liew [1995]. 
NO might inhibit the production of IFN-y by T hl cells [Taylor-Robinson et al., 
1994]. It is clear that in vivo and in vitro murine models showed the inhibitory 
effect of NO on the T cell proliferation. L-NMMA, a competitive inhibitor of NOS 
activity, reversed or elevated many T cell functions, such as cytokine production in 
experimental models of malaria [Taylor-Robinson et al., 1994]. Although there are 
some controversial reports using different experimental models and NO donors, it 
is likely NO has a dual effect on T cell proliferation. Thus, physiological 
concentrations of NO produced by constitutive NOS enzymes might result in T cell 
proliferation, but high levels of NO in response to cytokine stimulations in the 
immune system might inhibit T cell proliferation. The inhibition of la  antigen 
expressions on macrophages, as antigen-presenting cells (APCs), in response to 
NO has been reported. [Sicher et al., 1994].
I
1) The effect of IL-4 on PKC activity and NO synthesis induced by IFN-y and LPS 
in macrophages.
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A proliferative effect of NO on B cells has not been observed yet. Nevertheless, the 
antiproliferative effects of hydrogen peroxide and PGE2  have been observed 
[Albina et al., 1991]. On the other hand, a constitutive low level of NO production 
is present in the Epstein-Barr virus transformed human B cells and Burkitt's 
lymphoma cell lines [Mannick et al., 1994]. Figure 1.3. shows the interplay among 
the immune system cells and cytokines.
1.6. AIM OF PROJECT:
The aim of this project is to investigate the signalling pathways in macrophages, 
leading to nitric oxide production, with special interest in the role o f  
serine/threonine kinases, such as cAMP-dependent protein kinase, and protein 
kinase C. We will concentrate on how IL-4, a physiological agent, regulates NO 
synthesis in the macrophage-like cell line, J774.
Specifically, we will investigate the following points to explain the NO producing 
pathways in response to IFN-y and LPS in murine macrophages; %
2) The effect of intracellular cAMP elevation, transiently or sustained, on NO 
production and PKC activity in response to IFN-y and LPS.
3) The exploration to see whether or not PLA2  activation and arachidonic acid 
metabolites are involved in the NO-producing pathway in response to IFN-y and 
LPS in macrophages.
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CHAPTER 2
MATERIALS AND METHODS
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2. MATERIALS AND METHODS:
2.1, Materials:
J774 and RAW 264 cells were obtained from the American Type Culture Collection 
(ATCC). Murine recombinant IFN-y (activity 10^ unit/ml) was kindly provided by 
Dr. G. Adolf, Ernst-Boehringer Institut fur Arzneimittel-Forschung, Vienna, 
Austria. Murine recombinant IL-4 (activity 10^ unit/mg; lOOpg/ml^lO^ unit/ml) 
and monoclonal antibodies for IL-4 receptor (niAb IL-4r) were obtained from 
Genzyme (Cambridge, MA.). The PKC inhibitor, Ro31-8220 [Davis et al., 1989], 
was kindly provided by Dr. G. Lawton, Roche Products Limited, Hertfordshire, 
UK. Rolipram, a specific cAMP phosphodiesterase inhibitor, was obtained from 
Schering Ahtiengesellschaft (Germany). LPS from Salmonella enteritidis, prepared 
by phenol extraction, was obtained from Sigma. It was dissolved at 1 mg/ml in 
RPMI 1640 medium as a stock solution and stored at -20^C. Prostaglandin E2 
(PGE2 ) was obtained from Sigma and stored at 5 mg/ml in ethanol at -2 0 ^C. 
Adenosine-3’ : 5'- cyclic phosphorotiolate-Rp (Rp-cAMP), a PKA inhibitor, was 
purchased from Calbiochem-Novabiochem (UK) Ltd. [^H]- phorbol dibutyrate 
([^H]-PDBu), radio-labelled cAMP-binding assay kits for the measurement of 
cAMP, and PKC assay kits were obtained from Amersham International pic. 
(Amersham, England). Primers for the polymerase chain reaction (PCR) were 
kindly provided by Wellcome Research Laboratories (Beckenham, Kent, England). 
RNAzol B was obtained from Biogenesis (Bournemouth, England). Moloney 
Murine Leukaemia Virus Reverse Transcriptase (M-MLV RT) and reverse 
transcriptase buffer were obtained from Gibco BRL (Paisley, Scotland). Other 
reagents used in reverse transcription and PCR were from Promega (Madison, WI, 
USA). All other reagents were obtained from Sigma (Poole, Dorset, England).
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2.2. Methods:
2.2.1. Cell storage and culture:
Cell lines, J774.1 or RAW 264.7 macrophages, were stored in RPMI 1640 
containing 10% dimethylsulphoxide (DMSO) in freeze vials in a liquid nitrogen 
tank at approximately -168^ C. When needed, cells were obtained from this store; 
they were thawed suddenly under cold tap water and centrifuged at 1200 RPM 
(approximately 250 g) for 5 minutes and placed in RPMI 1640 medium (Flow 
Laboratories, Irvine, Scotland), without DMSO, supplemented with 10% heat 
inactivated-foetal calf serum (HI-FCS) (Gibco, Paisley, Scotland), 2mM L- 
glutamine (Row Laboratories), 100 U/ml penicillin and 100 pg/ml streptomycin 
(Flow Laboratories). For routine culture, cells were grown in 25 or 75 ml flasks 
(Costar) and incubated at 37^C in 5% CO2 . Every 3-4 day, cells were subcultured 
by scraping and placing into new flasks and diluted 5-10 times to supply nutrition 
and space enough for growth. I
2.2.2. Obtaining fresh peritoneal macrophages from CBA mice;
.^1 '
Four days after intraperitoneal injection with 4% Brewer's thioglycollate broth, 
peritoneal cells were harvested with RPMI 1640 medium from female CBA mice 
(Harlan Olac, Bicester, Oxon, UK.), 8-12 week old. The cells were cultured with 
RPMI 1640 medium containing 2mM L-glutamine, 50U/ml penicillin/100 pg/ml 
streptomycin and 10% heat inactivated FCS in either flasks or plates at 37°C in an 
atmosphere containing 5% CO2 . The cells were allowed to adhere for 2 hours.
After 2  hours, nonadherent cells were removed by washing the plates and replacing 
medium.
I
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2.2.3. Induction and measurement of NO synthesis:
J774 cells were cultured at 5x10^/ ml or 1x 10^/ ml in 96 or 24-well flat-bottomed 
plates (Costar), respectively, with various reagents as detailed in the Result chapters 
and incubated at 37®C in 5% CÜ2 . Supernatants were collected after 24 or 48 hr 
incubation, and NÜ2  concentrations determined by chemi 1 uminescence as
described previously [Palmer et al., 1987] and summarised below or by the Griess 
Method. The oxidation products of L-arginine in murine macrophages have been 
characterised to be L-citrulline and NO, which is rapidly converted into nitrite and 
nitrate in the presence of molecular oxygen [Marietta et aï., 1988; Stuehr and 
Marietta, 1987]. Nitrite and nitrate levels detectable in supernatants of activated 
murine macrophages thus reflect the formation of NO. Therefore, these 
concentrations are indicative of the amount of NO produced by the cells [Marietta et
al., 1988].
a
2 .2 3 .1 . Chem ilum inescence:
■
Luminescence is the emission of light or radiant energy when an electron returns 
from an excited or higher energy level to a lower energy level. There are several 
types of luminescence phenomena including fluorescence, phosphorescence and 
chemiluminescence [Tietz, 1986]. In chemiluminescence, the excitation event is 
caused by a chemical reaction and not by photoillumination. The physical event of 
the light emission in chemi luminescence is similar to fluorescence in that it occurs 
from an excited singlet state and the light is emitted when the electron returns to 
the ground state. Chemiluminescence involves the oxidation of an organic 
compound, such as nitric oxide, by an oxidant. In this event, the oxidising agent is 
oxygen itself with the emission of light occurring from the excited product formed 
in the chemical reaction [Tiffany, 1986]. Supernatants from samples and standard 
solutions, obtained by diluting 10“^  M stock NaN02" solution, were injected by
I
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Hamilton syringes (100 pi) into a boiling flask at approximately 95°C, containing 
%6 Nal (sodium iodide) and glacial acetic acid at the ratio of one in three (v/v), 
respectively. Nitric oxide (NO) in samples or standards were released in this boiling 
media, then NO and evaporated glacial acetic acid passed through tubes in a dry ice 
box, where the acid was trapped and NO alone passed through the plastic tubes. 
Gas, containing NO to be measured, comes into the machine's reaction chamber, 
which is connected to the ozone generator, and the NO rapidly reacts with ozone to 
generate a chemiluminescence product. Then, the chemiluminescence product is 
propelled with high speed into the detection chamber. An optical filter is inserted 
between the reaction chamber and the photomultiplier tube to provide a gas seal and 
yet allow the photons to pass from the reaction chamber to the photomultiplier tube. 
The photomultiplier tube is an integral part of the detector cell. The function is to 
convert to the low-level light (photons) produced by the gas phase 
chemiluminescent reaction between ozone and the NO in the reaction chamber into 
electrical energy and to amplify this electrical energy, and this is detected by the 
chemiluminescence device as parts per billion (ppb). which is shown on a digital 
displayer. Standard curves were obtained by using 2, 5, 10, 20, 50, and 100 p,M 
concentrations of NaN02", then samples were compared with the curve values to 
obtain their values as molar concentrations.
2.2.3.2. Griess reaction;
In this technique, the nitrite production by macrophages is determined 
colorimetrically. Supernatants, obtained as detailed above, were mixed with equal 
volumes of the Griess reagent (one volume of 0.1% (w/v) naphthylenediamine 
dihydrochloride and one volume 1% (w/v) sulphanilamide in 5% (v/v) phosphoric 
acid) in 96-well flat-bottomed plates. The mixture was incubated at room 
temperature for 10-30 min and the absorbances at 490 or 570 nm of each well were 
measured with a plate reader (Dynatech MR5000), and evaluated by Mikrotek 5.0
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Laborsysteme GMBH, version 4.0 software, using a 3865 XP/16 IBM compatible 
Toshiba Laptop computer. Printouts were taken from (Star LC-20, Dot Matrix 
printer). Standard curves were obtained by using NaN02” solution at 6.25, 12.5, 
25, 50 and 100 pM.
2.2.4. Determination of NO synthase activity;
J774 cells were incubated at 1 x 10^ cells/ml in 24-well plates for 12 hours with 
various reagents as detailed in Results. NOS activity in cell extracts was determined 
by a modification of a previously described method, based on the conversion of L- 
arginine to L-[lJ14c] citrulline and NO [Severn et al., 1993; Salter et al.,
1991]. Medium was then removed, and extraction buffer (0.1 M Hepes, pH:7.4 
with 1 mM DTT and protease inhibitors; pepstatin 1 pM, amastatin 5 pM, Soya 
bean trypsin inhibitor 10 pg/ml, leupeptin 5 pM and aprotinin 2 pg/ml) added at 
100 pi per 10^ cells. The cells were subjected to three freeze-thaw cycles at -20*^0 
and 37°C, and NO synthase activity was measured in the cell extracts. Assay buffer 
(100 pi), consisting of 50 mM potassium phosphate, pH 7.2, 50 mM L-valine, 100 
pM NADPH, 1 mM L-citrulline, 20 pM L-arginine and L-[Ul^C] arginine (132 
pl/10  ml), 1 mM MgCl2 , 0.2 mM CaCl2  and 5 pM tetrahydrobiopterin (H4 B) was 
dispensed into Eppendorf tubes. Cell extract (20 pi) was added to each tube, with 
and without 12 pi of L-NMMA solution (0.01 M in distilled water) and the tubes 
were incubated at room temperature for 1 hr. The reaction was terminated by the 
addition of 1.5 ml water/Dowex-50W (H"  ^ cation exchanger) (1:1). The Dowex 
was allowed to settle for 10 min, centrifuged at 14 OOOx g at room temperature for 3 
minutes, then 0.5 ml of supernatant was removed from each tube, and L~[Ul4c] 
citrulline levels determined by liquid scintillation counting (Wallac Oy). ACPM 
values were obtained by subtracting the value of tube with L-NMMA from the value 
of tube without L-NMMA. Specific activity was calculated by using total count 
tubes (100 pi of the assay buffer including L-[ljl'^C] arginine, 2nmol). Results
I
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from triplicate cultures were expressed as pmole citrulline formed per mg protein 
per minute.
[Tube without L-NMMA - Tube with L-NMMA] x [Amount of L-Arginine added! 
Total counts x Time x [Amount of protein added]
Where; Total counts=The total numbers of counts in 100 pi of the assay buffer. 
Time= Incubation time (60 minutes)
L -[u 1 4 c ] arginine was obtained from Amersham Int. and H4 B from Dr. B. 
Schircks, Jona, Switzerland. All other reagents used in this assay were from 
Sigma. Protein concentrations were measured by a Coomassie blue dye binding 
method using a protein assay kit from Pierce (Rockford, IL), as recommended by 
the manufacturer.
2.2.5. Measurements of protein concentrations in cell extracts;
2.2.5.1. Coomassie dye binding:
A Coomassie based protein assay was used that incorporates a modification of 
Bradford's technique [1976], based on the shift in absorbance maximum of 
Coomassie brilliant blue G, from 465 to 595 nm, when it binds to protein. The 
reagent was supplied by Pierce and Warringer. Protein standards were diluted from 
2 mg/ml bovine serum albumin (BSA) stock solution in sterile distilled water, 
including an equal volume of sample buffer to; 200, 100, 50, 25 and 12,5 pg/ml. 
Samples to be measured were diluted in distilled water as 1 in 10. Fifty pi of 
standards and extracts of cells, were put in wells of 96-well plates. Similar 
volumes of Coomassie solution were added wells. The plate was incubated at room 
temperature for 30 minutes and the absorbance at 570 nm of each well was
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measured with a plate reader (Dynatech MR5000), and evaluated by software 
Mikrotek 5.0 (Laborsysteme GMBH, version 4.0), using a 3865 XP/16 IBM  
compatible Toshiba laptop computer.
2.2.5.2. Micro BCA (Bicinchoninic acid) assay;
Reagents were prepared fresh before use as follows;
Reagent A; 4% bicinchoninic acid (BCA)
Reagent B; 8 % Na2 C0 3 , 2% NaOH, 1.0 % Sodium tartarate and sufficient 
NaHC03, to adjust pH to 11.25 
Reagent C; 4% CUSO4 . 5H20
Reagent D; 100 volumes Reagent A+ 100 volumes Reagent B + 4 volumes Reagent 
C.
Standard solution; Standard solutions were prepared from 2 g/ml stock solution of 
bovine serum albumin (BSA), as follows; 500, 250, 125, 62.5 and 31.25 pg/ml in 
lysis buffer.
Fifty pi of samples were mixed with an equal volume of reagent D and heated at 
60^C for 1 hr. Samples were brought to room temperature and put into 96 well- 
plates as 100 pi volumes. Absorbances were read at 570 nm against a reagent blank 
(lysis buffer) in a plate reader (Dynatech MR5000), and evaluated by software 
Mikrotek 5.0 (Laborsysteme GMBH, version 4.0), using a 3865 XP/16 IBM 
compatible Toshiba laptop computer.
2.2.6. Measurement of intracellular cAMP concentrations;
cAMP was extracted from J774 cells by a modification of a previously described 
method [Renz et al., 1988]. Cells were cultured at 5 x 10^ or 10^ / well in 1 ml 
culture medium in 24-well tissue culture plates (Costar, Cambridge, MA.), then the 
medium was removed and the cells loosened by scraping with a disposable cell
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scraper. 200-250 pi boiling assay buffer (0.05 M Tris and 4 mM EOT A, pH: 7.5) 
was added to each well. The cells were transferred to eppendorf tubes (Scotlab, 
Coatbridge, Scotland) and boiled for 10 minutes, to coagulate proteins. The cells 
were then sonicated, the tubes centrifuged at 12000 x g for 10-20 minutes at 4®C, 
and cAMP measured in the supernatants, using a radio labelled binding assay kit 
(Amersham International pic, Amersham, UK), as recommended by the 
manufacturer. Results were expressed as pmol/10^ cells.
2.2.7. Determination of [^H]-PDBu binding:
Specific binding of ^H-phorbol dibutyrate ([^H]-PDBu) to J774 cells was 
determined by a modification of a previously described method [Severn et al., 
1992b; Schutze et al., 1990]. Binding of [^H]-PDBu to whole cells predominantly 
reflects binding to the cell membrane [Schutze et al., 1990]. Scatchard analysis 
indicates that roughly one molecule of PDBu binds to one molecule of PKC in the 
presence of a physiological concentration of Ca^+ and an apparent excess of 
phospholipid [Kikkawa et al., 1983]. Cells (2-3 x 10^/well) were incubated at 
37^C in 96-well flat-bottomed plates, in the presence and absence of IL-4 (100 
U/ml) for 18 hrs, as detailed in results. Then cells were stimulated with IFN-y 
(40U/ml) and EPS (10 ng/ml) for 3 minutes. The medium was removed and the 
cells were washed three times with cold PBS. Cells were then incubated for 10 
minutes at 37^C with [^H]-PDBu (0.6 pCi/well), with or without 3nmol/well 
unlabelled 4a-phorbol-12,13-didecanoate (PDD) (Sigma), which does not stimulate 
PKC activation [Castagna et al., 1982]. Cells were harvested using an automatic 
harvester (Wallac Oy, Finland) and bound radioactivity counted in a betaplate 
counter (Wallac Oy). Specific binding of [^H]-PDBu was determined by 
subtracting binding in the presence of excess PDD (80 pg/ml) from total binding.
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2.2.8. Determination of PKC Activity:
Low-passage J774 cells were incubated for 48-72 hrs in 25 ml flasks in RPMI 
medium supplemented, as previously described. Medium was renewed daily. Cells 
in control flasks were counted and approximately 2  x 10^ cells per flask was 
accepted as a sufficient amount of cells for each experiment. Then, cells were 
washed 3 times with cold PBS and scraped with disposable cell scrapers into 
eppendorf tubes and centrifuged for 5 minutes at 10,000 x g. Supernatant was 
removed and 1 ml of extraction buffer (50 mM Tris/HCl, pH: 7.5 with 1 pM 
pepstatin A, 5 pM amastatin, 10 pg/ml soya bean trypsin inhibitor, 5 pM leupeptin,
2 pg/ml aprotinin, 10 mM benzamidine, 50 pl/ml phenylmethylsulphonylfluoride, 5 
mM EDTA, 10 mM EOT A, 0.3% w/v p-mercaptoethanol and 50 pg/ml digitonin) 
added. The cell suspensions were then sonicated 5 times for 10 sec. each with an 
ultrasonic generator (Branson Sonifier, model 250) with a tip diameter of 3 mm, 
output adjusted to 2 0  and tuning 1, and cells were kept on ice between sonication 
periods. Eppendorf tubes were centrifuged for 30 min at 10,000 x g. The 
supernatants were used for PKC determination using an assay kit (Amersham Int.
Pic), as recommended by the manufacturers.
2.2.9. RNA extraction and reverse transcription:
3x10^ J774 cells were incubated at 37^C for 3-5 hours, then total RNA was 
extracted from J774 cells using RNAzol B (Biogenesis, Bournemouth, UK.), as 
recommended by the manufacturer. The RNA isolation was carried out by a single- 
step procedure, as described by the inventors [Chomczynski and Sacchi, 1987].
The RNAzol B method is completed within 1.5-2 hrs. Firstly, cells were
-homogenised by using RNAzol B solution (400 pi), then 80 pi chloroform was 
added to extract RNA, and tubes were shaken for 15 seconds. After 15-20 minutes 
on ice, the tubes were centrifuged at 13000xg in a microfuge for 15 minutes.
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Supernatants were removed, and an equal volume of isopropanol was added to 
precipitate RNA. After a 20 minute incubation on ice or in a cold room (+4®C), 
tubes were centrifuged at ISOOOxg for 20 minutes, then pellets often visible were 
obtained, forming a white-yellow pellet at the bottom of the tube. Pellets were 
washed by using ice-cold ethanol (800 pi for each tube). Finally, the tubes were 
centrifuged for 10 minutes, then pellets were dried by using a vacuum drier. Pellets 
were dissolved in sterile distilled water and absorbances were measured. Samples, 
having a 260/280 ratio between 1.6 and 2 .1, were used for reverse transcription. 
Two pg in a total volume of 20  pi was reversed transcribed, using Moloney 
leukaemia virus reverse transcriptase and random primers (Promega, Madison, WI, 
USA). The reaction mixture, including 0.5 pi RNAsin (40 U/ml), 4 pi 5xRT 
buffer, 2 pi dithiothreitol (DTT) (100 mM), 2 pi dextro-nucleoside triphosphates 
(dNTPs) (10 mM), 1 pi random primer, 1 pi reverse transcriptase and sample 
RNA, was left at room temperature for 10 minutes to allow annealing of the primer 
to its target sequence, then incubated at 37^C for 60 minutes.
2.2.10. Polymerase chain reaction:
Four microliters of reverse transcription mixtures from each tube were used for 
PCR, as cDNAs. Polymerase chain reaction (PCR) amplification of cDNA was 
then  ca rried  o u t, u sing  p rim ers fo r m u r in e  iNOS ( 3 -  
TTCCGAAGTTTCTGGCAGCA; 5-ATAGGAAAAGACTGCACCGAAGAT) 
and p-actin (3'-CTCTTTGATGTCACGCACGATTTC; 5'-GTGGGCCGCT 
CTAGGCACCAA). Primers for iNOS were synthesised at the University of 
Glasgow by Damo Xu, and primers for p-actin were obtained from British 
Biotechnology (Oxon, UK.). Two microliter of the reverse transcription reaction 
was made up to 100 pi with 1 xTaq buffer containing 0.5 pg of the 5' primer, 0.5 
pg 3' primer and 2.5 U Taq polymerase (Promega, Madison, WI, USA), p-actin 
3' and 5' primers were used as a control. 2.5 mM dNTPs were used for each tube.
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Thirty-five amplification cycles were carried out, each cycle consisting of 1.5 
minutes at 94^C, 2 minutes at 55°C and 3 minutes at 72^C. PCR products were 
separated by electrophoresis through 1 % agarose containing ethidium bromide, and 
viewed by UV illumination.
2.2.11. Detection and analysis of proteins: SDS Page and 
Western Blotting:
J774.1 cells were set up in 25 ml culture flasks and adjusted to 1 x 10^ cells/group. 
RPMI 1640 medium supplemented by some factors as described before was 
renewed before treatments as detailed in related experiments. Medium was removed 
and then cells were washed by ice cold PBS twice. Cells were scraped into 5-10 ml 
sterile PBS and centrifuged at 250 x g for 3-5 minutes, and proteins were dissolved 
in extraction buffer (400 pi), containing 150 niM NaCl, 1 % NP-40 (Nonidet-P- 
40), 1 mM EDTA, 2 mM EOT A, 1 mM DTT, 50 pg/ml leupeptin, 50 pg/ml 
aprotinin and 50 pg/ml PMSF in 25 mM Tris-HCl buffer (pH:7.5). Cells in 
extraction buffer were homogenised and kept on ice for 20-30 minutes, then 
centrifuged at 13 OOOxg for 10 minutes. Supernatants were used immediately for 
protein measurements and running SDS-polyacrylamide gel. Protein measurements 
were carried out as described below in this chapter.
Gel tanks were washed and cleaned by using ethanol before use. 30% acrylamide 
mix, 10% SDS, 1.5 M Tris-HCl (pH:8 .8 ), 10% ammonium persulphate and 
tetramethylethylenediamine (TEMED) in distilled water were solutions to prepare 
the lower gel (resolving gel), which was prepared by mixing these solution 
components in different portions to obtain 7.5% of SDS-polyacrylamide gel for 
samples as detailed in related experiments. The mixture was poured into the gap 
between the glass plates, leaving sufficient space for the stacking gel (Upper gel) 
immediately after mixing it, because polymerisation will begin as soon as the
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TEMED has been added. 1-2 ml distilled water was added onto the gel to prevent 
oxygen diffusion into the gel. The gel was placed in a vertical position at room 
temperature. After gel polymerisation is completed (approximately 30 minutes), the 
overlay was poured off and the top of the gel was washed several times with 
deionized water to remove any unpolymerized acrylamide. The stacking gel, 
including appropriate volumes of 30% acrylamide, l.OM Tris-HCl (pH:6 .8 ), 10 %
SDS, 10% ammonium persulphate and TEMED in distilled water, was prepared, as 
detailed in related experiments. The stacking gel solution was poured directly onto 
the surface of the polymerised resolving gel. A clean Teflon comb was inserted into 
the stacking gel solution, being careful to avoid trapping air bubbles. The gel was 
then placed in a vertical position at room temperature. After polymerisation is 
completed, approximately in 30 minutes, the Teflon comb was removed carefully.
The wells were immediately washed with deionized water, using a squirt bottle, to 
remove any unpolymerized acrylamide.
:'The gel tank was mounted in the electrophoresis apparatus. Tris-glycine buffer (pH:
8.3) was prepared, using 25 mM Tris, 250 mM glycine and 0.1 % SDS, to add to 
the top and the bottom reservoirs after samples were loaded. Samples were loaded
10-20 pg protein/well after dénaturation by boiling for 5 minutes in SDS gel-
.loading buffer, containing bromophenol blue as a tracking dye to follow the 
process. Rainbow markers were used to determine the weights of the protein bands
:investigated. The positive electrode was connected to the bottom and the negative 
one to the top reservoir, and the current of 20 mA was used to separate the proteins.
After the dye front has reached the bottom of the resolving gel, the power supply I
was turned off.
For western blotting, the gel was transferred into transfer buffer immediately. 
Transfer buffer contains 39 mM glycine, 48 mM Tris base and 20 % methanol. 
Proteins were transferred onto a nitro-cellulose membrane (BioRad, Hempstead,
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USA), applying 300 mA current for 1-2 hours. Nonspecific binding sites were 
blocked with 2% BSA in wash buffer 1, containing 0.01 M Tris HCl (pH:7.5), 0.1 
M NaCl and 0.1% Tween-20, at 4^C overnight. Next day, the primary antibody, 
mouse ab a  iNOS (1/200), was added in 1% BSA, then the membrane was left 
shaking for 1 hour. The membrane was washed with wash buffer 1 twice for 10 
minutes, and wash buffer 2 , including 0.01 M Tris HCl (pH:7.5), 0.5 M NaCl and 
0.1% Tween-20, twice for 10 minutes each, finally, wash buffer 1 again. The 
secondary antibody, mouse ab a-HRP (1/5000), was added onto the membrane, 
and incubated for 1 hour. A further cycle of washing was carried out (WB 1x2, 
WB2x2, W Blx2) for 10 minutes each. Finally, enhanced chemiluminescence 
(ECU) solutions were used to visualise proteins by luminescence and exposing it 
onto a Kodak film in a dark room. ECL solution A and B (1:1, v/v) were added into 
a tank, containing membrane, and shook for 1 minute, then used to expose the film.
2.2.12. Cell viability tests:
2.2.12.1. Trypan Blue Exclusion Test;
i
V'•
i
All reagents to modify cell functions were assayed for any possible cytotoxic effects 
by several techniques; Trypan blue exclusion test and glucose uptake assays.
96-well plates were used for this test. Wells including cells treated by ÏBMX or
■:
Other appropriate agents for 24 hours or controls were washed by warm PBS twice 
after removing RPMI 1640 medium supplemented as indicated above. Fifty pi 
trypan blue dye (1 % in saline, w/v) was added into wells. Then, the plate was 
incubated for 3-5 minutes in room temperature. The trypan blue solution was 
removed and cells were observed with a Zeiss microscope. Dead and surviving
;
cells in at least nine randomly selected areas were counted. Results have been 
shown as the ratio of [total cells] - [stained cells] x 100/ [total cells]. Percentages
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;for cell viability expressed with SD values were indicated in the related 
experiments.
2.2.12.2. Glucose uptake:
Cells were adjusted to a density of 1x10^ cells/well in 1 ml RPMI 1640 medium to 
check, if cells were damaged by various substances. Two pCi/ml pH]-glucose was 
used to determine this effect. Cells were treated with 2 pCi/ml pH]-glucose in 
RPMI 1640 medium. Then test medium (1 ml) containing appropriate substances 
was added. Cells were treated with agents, such as cholera and pertussis toxins, 
IBMX, and untreated cells were used as controls, and the incubation was continued 
at 37^C for 24 hrs. After, 24 hours, this medium was removed, the wells were 
washed four times with sterile warm PBS. This was sufficient to eliminate 
unincorporated radioactive pH]-glucose from wells, counting p-radiation each
time. The cells remaining in each well were treated with 0.1 % Triton X-100 in 
PBS for 5 min to lyse the cells. One ml of lysate was also added to scintillation
vials and counted for pH] on a scintillation counter. Sodium azide (0.01 M) treated 
wells were used as positive controls. The percentage uptake of pH]-glucose was 
presented as CPM values for each group [Andreoli et al., 1985].
2.3. Statistical Analysis;
All experiments were carried out at least two or three times. Statistical significance 
(**: p<o.01, p<0.05, f: p<0.1, n=3) was analysed by student's paired t -test.
Standard error of means (SEM) or standard deviation (SD) bars of sample 
measurements have been shown where required.
Ü
CHAPTER 3
THE EFFECT OF PROLONGED ELEVATION OF cAMP LEVELS 
ON NITRIC OXIDE PRODUCTION BY .1774 MACROPHAGES
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3.1. INTRODUCTION
Nitric oxide plays an important role in the tumoricidal and anti-microbial activities 
of macrophages [Stuehr and Marietta, 1985], However, as its cytotoxic effects are 
non-specific, it is important that its production is regulated. NO production is 
inhibited by cytokines such as IL-4 [Liew et al., 1991] and TGF-p [Ding et al., 
1990]. The production of TNFa and IL-1 by macrophages is inhibited by agents 
which increase intracellular cAMP concentrations, including adenylyl cyclase 
activators, such as PGE2  [Kunkel et al., 1986; Renz et al 1988; Hart et al., 1989a] 
and p - adrenergic agonists [Severn et al., 1992a], and nonspecific cAMP 
phosphodiesterase inhibitors [Stricter et al., 1988]. It is important to indicate that 
PGE2  is the major cyclooxygenase product synthesised in macrophages activated 
by bacterial LPS [reviewed by Bonney and Humes, 1984]. It has been reported that 
increased intracellular cAMP levels direct a negative signal for several immune 
responses [Smith et al., 1971; Bourne et al., 1974; Kammer et al., 1989; Chouaib 
et al., 1987], such as cytotoxicity and conjugate formation by mouse CTL [Gray et 
al, 1988] and the TcR-induced increase of adhesion [Dustin and Springer, 1989].
Cyclic AMP activates PKA, which phosphorylates many proteins, some of which 
function in the nucleus to alter gene transcription, such as CREB protein. It has 
been reported that cAMP-elevating agents alter transcriptional induction of iNOS 
mRNA in rat glomerular mesangial cells [Kunz et al., 1994]. The PKA enzyme is 
composed of two regulatory (R) and two catalytic (C) subunits that together 
constitute an inactive holoenzyme of an R2 C2  structure. Binding of cAMP to the 
regulatoiy subunit dimer results in release and concomitant activation of the catalytic 
subunits. The catalytic subunit requires that substrates have basic amino acids that 
precede the site of phosphotransfer with the consensus sequence for recognition; 
being Arg-Arg-X-Ser [reviewed by Bramson et al., 1984]. iNOS displays a 
consensus site for phosphorylation by PKA located at a site different for the
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comparable sequence in cNOS. In both cNOS and iNOS this is a weak 
phosphorylation sequence, Lys-Arg-X-X-Ser [Lowenstein et aL, 1992].
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We have therefore investigated the effect of increased cAMP levels on NO 
production by using a murine macrophage cell line, J774. Prostaglandin E2  alone 
induced a brief increase in intracellular cAMP concentrations and did not affect NO 
production, but PGE2  and a nonspecific phosphodiesterase inhibitor IBMX, in 
combination induced a prolonged elevation of cAMP levels and inhibited NO 
production. It should be added that the phosphodiesterases consist of a family of 
more than 30 members, all of which may be inhibited by IBMX [reviewed by 
Beavo et al., 1994]. Rp-cAMP, a nonhydrolysable inhibitor of cAMP-dependent 
kinase (PKA) [Botelho et al., 1988] prevented the inhibition of NO production by
PGE2  and IBMX, confirming that the effect was dependent on cAMP itself. In
addition, by using rolipram, which is a cAMP-specific PDE inhibitor [Reviewed by 
Beavo and Reifsnyder in 1990], we demonstrated that there is no other effect of 
IBMX involved in this inhibition.
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3.2. RESULTS
3.2.1. c AMP-elevating agents inhibit NO production:
In macrophages, it is known that cAMP generation induced by PGE2 , cholera toxin 
and IBMX, or cAMP analogues added into medium, inhibits macrophage motility, 
phagocytosis and cytokine secretions. We tested the effect of cAMP elevation, 
induced by PGE2  or 8 -bromo-cAMP alone, and in combination with IBMX, on 
NO produced in response to high concentrations of LPS or IFN-y and low dose 
LPS. J774 cells, 5 x 10^ /ml in RPMI 1640 medium, were cultured in 96-well 
plates. Thirty minutes after adding cAMP-elevating agents, cells were stimulated by 
1 pg/ml LPS or IFN-y (40 U/ml) and low dose LPS (10 ng/ml), then incubated for 
24 hrs. Supernatants were used for measurement o f NO 2 " by using 
chemiluminescence.
Stimulation of J774 cells with 1 pg/ml LPS induced the production of NO (Figure 
3. La). Production of NO was not affected by PGE2  (10'^ M) or 8 -Br-cAMP (10"^
M) alone, but was significantly inhibited by the combination of PGE2  or 8 -Br- 
cAMP with IBMX (10'"^ M) (p<0.01). The PKA inhibitor, Rp-cAMP (4 x 10'^
'M), used to evaluate if this effect is due to cAMP itself, completely prevented 
inhibition.
NO production induced by IFN-y and low dose LPS was also inhibited by PGE2  or 
8 -Br-cAMP, in combination with IBMX, and the inhibitory effect of cAMP- 
elevating agents was prevented by Rp-cAMP (p<0.01) (Figure 3. Lb).
In the absence of agents which increase cAMP, Rp-cAMP had no effect on NO 
production. IBMX alone, in cells stimulated by IFN-y and low dose LPS or high
■Edose LPS alone did not alter NO production. Since IBMX (100 mM) was dissolved
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in DMSO, controls carried out showed that the results were not affected by DMSO 
(maximum concentration 0.1  % v/v).
Cell viability was examined by trypan blue exclusion in cells treated with IBMX, 
and it has not been found that IBMX (10"^ M) has a toxic effect on cells 
(CV>96%). Moreover, cells treated with IBMX were able to adhere and spread in a 
similar fashion to untreated cells, and the general morphology appeared normal.
3.2,2. P G E 2  and IBMX pretreatment of J774 cells is required to  
inhibit NO production in response to IFN-y and low doses of LPS:
It is required to observe the best time point for usage of cAMP-elevating agents to 
inhibit NO production in response to IFN-y and LPS in macrophages. Then, it 
might be possible to predict where and how this effect alters NO production.
(p<0.05).
The response of J774 cells to produce NO, following stimulation by IFN-y (40 
U/ml) and LPS (10 ng/ml), was assessed by using PGE2  (10"^ M) and IBMX (10" 
M) at different time points. Cells were treated with PGE2  and IBMX at different 
time points (-18, -4, -1/2, 0, +4 hours) and stimulated by IFN-y and LPS, and then 
cultured for 24 hours. Supernatants were used for measurement of NO2" by using 
chemiluminescence.
The best inhibition, approximately 35 %, was observed, when cells were treated
with PGE2  and IBMX 30 minutes before stimulation (p<0.01) (Figure 3.2). This
evidence shows that the inhibitory effect of cAMP elevation on NO producing 
macrophages requires pretreatment of J774 cells with cAMP-elevating agents. 
However, the treatment of cells with PGE2  and IBMX after 4 hrs stimulation 
inhibited NO production in response to IFN-y and LPS, This inhibition was less 
than the inhibition caused by pretreatment of cells, but was statistically significant
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Figure 3. l.a : The effect of PGE2  (10'^ M) or 8 -Br-cAMP (10‘^M ) with 
IBMX (10"^ M) on NO production in response to LPS (1 pg/ml), and the effect of 
Rp-cAMP (4 X 10"^ M) in J774 cells. Cyclic-AMP elevating agents were added 30 
min after adding Rp-cAMP and 30 min before stimulation with LPS (1 pg/ml). The 
means ± SEMs of triplicate samples are shown. Results are representative of three 
separate experiments.
(**: p<0.01, n=3)
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Figure 3.1.b: The effect of PGE2  (10"^ M) or 8 -Br-cAMP (10"^ M) with 
IBMX (10"'^ M) on NO production in response to IFN-y (40 U/ml) and LPS (10 
ng/ml), and the prevention by Rp-cAMP of this inhibition in J774 cells. Cyclic 
AMP-elevating agents were added 30 min after adding Rp-cAMP (4 x 10"^ M) and 
30 min before stimulation with IFN-y (40 U/ml) and LPS (10 ng/ml). The means ±
SEMs of triplicate samples are shown. Results are representative of three separate 
experiments.
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Figure 3.2; The effect of PGE2  (10'^ M) and IBMX (10"^ M) used at different 
time points on stimulation with IFN-y (40 U/ml) and LPS (10 ng/ml) in J774 cells 
(5 X 10^ cells/ml). Control shows nitrite measurements by chemiluminescence in  
samples obtained from resting J774 cells. Since IBMX (100 mM) is dissolved in 
DMSO, controls carried out showed that the results were not affected by DMSO 
(maximum concentration 0.1 % v/v). The means ± SEMs of triplicate samples are 
shown. Results are representative of three separate experiments.
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3.2.3. The effect of PGE2 and IBMX on intracellular cAMP levels:
Cells were incubated with 10"^ M PGE2 , alone or with 10"^ M IBMX, and cAMP 
was extracted and measured, as described in Chapter 2. PGE2  alone resulted in an 
increased cAMP level, detectable at 15 minutes. However, PGE2  alone causes 
transient cAMP elevation in cells, which disappears 1 hour after treatment. The 
combination of PGE2  and IBMX induced a greater rise in cAMP, and the level was 
still elevated after 8  hours. This result shows the difference between use of PGE2 
alone and together with IBMX. It is clear that the inhibitory effect of cAMP 
requires elevated and sustained levels of cAMP. Results are expressed in pmol/10^ 
cells, and means and standard deviations of triplicate samples are shown (Table 
3.1).
3.2.4. Short-term cAMP-elevating agents do not have an effect on 
NO production:
Cells were adjusted to 5 x 10^ cells in each well in RPMI 1640 medium 
supplemented with 10 % ECS, L-glutamine and antibiotics. 8 -Br-cAMP at graded 
concentrations, was added into the medium 30 min before stimulation. Then, cells 
were stimulated with high concentrations of LPS (1 pg/ml) or IFN-y (40 U/ml) and
low dose LPS (10 ng/ml), and incubated for 24 hrs. Supernatants were used for 
NO2 '  measurement by chemiluminescence, as detailed in Chapter 2 .
8 -Br-cAMP did not affect NO production by J774 cells in response to high 
concentrations of LPS (1 pg/ml) or IFN-y (40 U/ml) and low dose LPS (10 ng/ml) 
(Figure 3.3). This result demonstrate 8 -Br cAMP, which is a membrane analogue 
of cAMP, does not affect J774 cells at any concentration.
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Table 3.1: Intracellular cAMP levels in response to cAMP 
elevating agents:
cAMP (pmol/ 1Q6  cells)
Time PGE2 PGE2  + IBMX IBMX alone Controls
0 < 1 < 1 < 1 < 1
15 mins 32.5 ± 2.01 65.87 ± 6.00 < 1 < 1
1 hr < 1 19.60 ± 3.96 < 1 < 1
2  hrs < 1 13.07 ± 1.22 < 1 < 1
4 hrs < 1 11.47 ±0.92 < 1 < 1
8  hrs < 1 9.87 ± 1.85 < 1 < 1
12 hrs < 1 < 1 < 1 < 1
24 hrs < 1 < 1 < 1 < 1
The comparison of cAMP levels elevated by PGE2  (10“^  M) and IBMX (10""  ^M) 
or PGE2  ( 10"^ M) alone at different time points. J774 cells were cultured at 10^ 
cells in 1 ml medium, and then cAMP was extracted and measured as described. 
Results are expressed in pmol/10^ cells. Results are representative of three separate 
experiments. The means and standard deviations of triplicate cultures are shown. 
(n=3)
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Figure 3.3: Short-term cAMP-elevating agents do not affect NO production in 
J774 cells. 8 -Br-cAMP, which is a membrane analog of cAMP, is used, and there 
is no inhibitory effect of the agent at a variety of concentrations on NO production 
by J774 cells in response to high concentrations of LPS (1 pg/ml) alone or IFN-y 
(40 U/ml) and low dose LPS (10 ng/ml). Controls show nitrite measurements by 
chemiluminescence in supernatants, which have been obtained from resting J774 
cells. Results are representative of three separate experiments. The means ± SEMs 
of triplicate samples are shown. (n=3)
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3.2.5. Prolonged elevation of cAMP levels in J774 cells inhibits 
iNOS activity in response to IFN-y and LPS;
It is required to investigate the effect of cAMP elevation on iNOS activity. The 
effect of cAMP-elevating agents on iNOS activity produced by J774 cells in 
response to IFN-y (40 U/ml) and LPS (10 ng/ml) was assessed, as detailed in
Chapter 2. Cells were adjusted to 1 x 10^ cells in 1 ml medium. cAMP-elevating 
agents were added 30 min before stimulation and 30 min after adding Rp-cAMP (4 
X 10"^ M), then cells were stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml) for
12 hours. Cytosols were extracted, as detailed in Chapter 2, and iNOS activity was 
measured by the citrulline assay.
The effect of PGE2  (10“^  M), in combination with IBMX (10""^ M), resulted in a 
significant decrease in iNOS activity (p<0.05). The combination of 8 -Br-cAMP 
(10 '^  M) and IBMX (10'"^ M) also inhibited iNOS activity (p<0.05). The PKA 
inhibitor, Rp-cAMP (4 x 10 M), completely prevented inhibition in both cases
(Figure 3.4). These results indicate clearly that sustained elevated intracellular 
cAMP inhibits NO production by inhibiting iNOS activity.
I:
if
I
3.2.6. There is no difference in the level of inhibition between usage 
of IBMX, a nonspecific PDFs Inhibitor, and Rolipram , a cAMP- 
specific-PDE inhibitor:
Since IBMX is a nonspecific PDEs inhibitor, and may additionally inhibit some 
PLC isoforms, it is necessary to clarify that the inhibition of NO production by
J774 cells is due to cAMP elevation itself, but not other interferences in signalling 
pathway. The effects of PGE2  or 8 -Br-cAMP alone, and in combination with 
IBMX or rolipram, on NO production were assessed. J774 cells, 5 x 10 /ml in 
RPMI 1640 medium, were cultured in 96-well plates, then cells were treated with
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IBMX (10"^ M) or rolipram (10"^ M), and PGE2  (10"^ M) or 8 -Br-cAMP (10“^  
M) for 30 minutes. Cells were stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml) 
or LPS (1 pg/ml) alone. After 24 hours incubation, NO2 '  was determined, using 
chemiluminescence, in supernatants.
Both IBMX and rolipram, together with PGE2  or 8 -Br-cAMP, caused the 
inhibition of NO production in macrophages stimulated by IFN-y and low dose 
LPS or high dose LPS alone (p<0.01-0.1) (Figure 3.5). In the absence of agents 
which increase cAMP, IBMX or rolipram had no effect on NO production. Because 
IBMX (100 mM) and rolipram (10 mM) were dissolved in DMSO, controls were 
carried out, and the results were not affected by DMSO (maximum concentration 
0.1  % v/v).
Cell viability was examined by trypan blue exclusion in cells treated with IBMX or 
rolipram and it was found to be >95%. Moreover, cells treated with IBMX and 
rolipram were able to adhere and spread similarly to untreated cells, and the general 
morphology appeared normal.
3.2 .7 . PGE2 and IBMX do not have an effect on iNOS mRNA  
transcription in J774 cells stimulated by IFN-y and LPS:
The inhibitory effect of cAMP elevation might be transcrip tional or 
posttranscriptional. Transcriptional effects involve either downstream signalling 
induced by IFN-y and LPS or a direct nuclear effect of PKA activation, whereas
posttrancriptional effects involve iNOS phosphorylation and alterations of iNOS 
mRNA stability. Cells were adjusted to 5 x 10^ cells/ml and cultured in 25 ml 
flasks. Cells were treated with PGE2  (10"^ M) and IBMX (10“^  M) with or
without Rp-cAMP (4 x 10'^ M), a PKA inhibitor, for 30 min before stimulation 
with IFN-y, (40 U/ml) and LPS (10 ng/ml). Rp-cAMP was added 30
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Figure 3.4: The sustained elevation of cAMP levels inhibits iNOS activity in 
response to IFN-y and LPS. The effect of cAMP-elevating agents on iNOS activity 
produced by J774 cells in response to IFN-y (40 U/ml) and LPS (10 ng/ml) was
assessed. Cyclic AMP-elevating agents were added 30 min after adding Rp-cAMP 
(4 X 10"^ M) and 30 min before stimulation, then cells were stimulated by IFN-y
(40 U/ml) and LPS (10 ng/ml) for 12 hours. Controls show NOS activity 
measurements by citrulline assay in resting cells and Rp-cAMP treated cells. The 
means ± SEMs of triplicate samples are shown. Results are representative of three 
separate experiments.
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Figure 3.5: The comparison of IBMX with a cAMP-specific PDE inhibitor, 
rolipram. Cells were treated with IBMX (10"4 M) or rolipram (10"^ M), and PGE2 
(10'^ M) or 8 -Br-cAMP (10~^ M) for 30 minutes. Then, cells were stimulated by 
IFN-y (40 U/ml) and LPS (10 ng/ml) or LPS (1 pg/ml) alone. After 24 hours
incubation, NO2 '  was determined, using chemiluminescence, in supernatants. 
Controls were obtained from wells untreated, treated with rolipram and IBMX 
alone. Results are representative of three separate experiments. The means ± SEMs 
of triplicate samples are shown.
(**: p<0.01, p<0.05, p<0.1, n=3)
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for 10-12 hrs and medium removed. Cells were washed three times with sterile
min before adding the cAMP-elevating agents. Cells were incubated for 5 hrs and 
medium removed, then cells were washed three times with sterile warm PBS 
buffer. Cells were gently scraped and total RNA was extracted for reverse 
transcription and PCR, as described in Chapter 2. Reverse transcription and PCR 
have shown that cAMP-elevating agents have no effect on iNOS gene transcription. 
(Figure 3.6).
3.2.8. PGE2 and IBMX reduce iNOS protein synthesis in J774 cells 
stimulated by IFN-y and LPS;
Having shown that there was no the effect of cAMP-elevating agents on iNOS 
message, protein extraction, SDS-PAGE separation and western blotting were 
carried out to explore the post transcriptional alterations in NO production. Cells 
were adjusted to 5 x 10 cells/group and cultured in 25 ml flasks. Cells were treated 
with PGE2  (10“^  M) and IBMX (10"^ M) together or IBMX alone, then incubated
%
warm PBS buffer, and scraped into the extraction buffer, then cytosolic proteins 
were extracted for SDS-Page, as described in Chapter 2. Having run SDS- 
Page gel, proteins were transferred to solid phase, nitro-cellulose membranes as 
described in Chapter 2. The next day, the primary antibody, mouse anti-iNOS 
(1/200), was added in 1% BSA. Then the membrane was washed, as detailed in 
chapter 2. Secondary antibody, mouse ab a-HRP (1/5000), was added onto the 
membrane, and incubated for 1 hour. The membrane was washed once again. 
Finally, film was developed by ECL detection method.
The treatment of J774 cells with PGE2  and IBMX, when applied together, results 
in iNOS synthesis inhibition in response to IFN-y and LPS. PGE2 (10"^ M) and 
IBM X (10 M) were used 30 minutes before stimulation with IFN-y (40 U/ml) 
and LPS (10 ng/ml). In order to determine inhibition level of iNOS protein
99
synthesis in stimulated cells. (Figure 3.7).
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synthesis by PGE2  and IBMX, the extract of cells stimulated by IFN-y and LPS
were diluted at different ratios (1/2 and 1/4). Densitometer results have shown 
.approximately 65 % inhibition of iNOS protein synthesis, when the cells were 
treated with PGE2  and IBMX. Moreover, IBMX alone did not affect iNOS
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Lane 1: IFN-y + LPS
Lane 2: Resting cells (Controls)
Lane 3: IFN-y and LPS + PGE2  + IBMX
Lane 4: IFN-y and LPS + PGE2  + IBMX + Rp-cAMP
Figure 3.6: The effect of PGE2  and IBMX on iNOS gene transcription in J774
cells stimulated by IFN-y and LPS. Cells were treated with PGE2  ( 10 '^  M) and
IBMX (10"'^ M) with or without Rp-cAMP (4 x 10"^ M), which is a PKA inhibitor 
for 30 min before stimulation with IFN-y (40 U/ml) and LPS (10 ng/ml). Rp-cAMP
was used 30 min before adding cAMP-elevating agents. Reverse transcription and 
PCR have shown that cAMP-elevating agents have no effect on iNOS gene 
transcription. Controls show ^-actin bands in J774 cells. Experiments have been 
done three times.
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Figure 3.7: Western blot analysis as the effect of PGE2 and IBM X on iNOS 
synthesis in response to IFN-y and LPS. PGE2 (10”^  M) and IBM X (10”'^  M) 
were used 30  minutes before stimulation with IFN-y (40 U/ml) and LPS (10  
ng/ml). To determine inhibition level of iNOS protein synthesis by PGE2 and 
IBM X, the extract of cells stimulated by IFN-y and LPS were diluted at different
ratios (1/2 and 1/4) to measure protein levels by densitometer. Experiments have 
been repeated twice.
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3.3. DISCUSSION:
Data presented here demonstrate that NO production by murine macrophages is 
inhibited by a prolonged increase in intracellular cAMP concentrations. A non­
specific, toxic effect of PGE2  and IBMX was excluded by the use of a PKA 
inhibitor, which completely prevented the inhibition. Bromberg and Pick [1980] 
reported that macrophages treated with NO-generating agents showed an increase 
in cyclic GMP levels. Furthermore, NO generated by macrophage cytosol 
stimulates soluble guanylate cyclase [Mulsch et al., 1990]. These data suggest that 
macrophage cytotoxicity may also be related to the formation of cGMP. Since 
IBMX is a nonspecific PDE inhibitor, it might affect intracellular cGMP generation. 
IBMX has also an antagonist effect for adenosine receptors [Beavo and Reifsnyder, 
1990]. Therefore, it was required to be confirmed by using Rp-cAMP that the 
inhibitory effect of cAMP-elevating agents was directly due to cAMP elevation. 
Meanwhile, PGE2  was also inhibitory for the NO production, the inhibition 
observed in the presence of 8 -Br-cAMP is more likely be due to its action as a 
cAMP analogue and not to nonspecific effects of its breakdown products. 
Additionally, rolipram, which is a cAMP-specific PDE inhibitor, was used with 
cAMP-elevating agents PGE2  or 8 -Br-cAMP, and no difference was found 
between the usage of IBMX and rolipram (also called ZK62711) [Reviewed by 
Beavo and Reifsnyder in 1990]. One high affinity cAMP phosphodiesterase can be 
activated by cAMP-dependent protein kinase (PKA) [Anderson et al., 1989; Gettys 
et al., 1987; Kilgour et al., 1989; Macphee et al., 1988]. Therefore, IBMX use in 
experiments seems to be necessary to inhibit PDEs nonspecifically.
What could be the role of the cAMP pathway in the inhibition of NO production in 
macrophages? According to PCR, SDS-Page and western blotting results, it is clear 
that the inhibitory effect of cAMP elevation on NO production occurs at the post 
transcriptional or translational levels of iNOS gene and iNOS protein synthesis
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respectively, but not at the level of transcription. In fact, the mechanism by which 
cAMP inhibits NO production is still unclear, but the requirement for a prolonged 
increase in cAMP suggests that it acts at a translational or post-translational level. 
The macrophage iNOS has a consensus sequence for PKA phosphorylation 
[Lowenstein et al., 1992], and it may be that phosphorylation by this enzyme 
reduces the activity of NOS. Activated macrophages produce large quantities of 
PGE2 [Nathan, 1987], and this may contribute to the regulation of NO production, 
via the elevation of cAMP. On the other hand, PKA activity can cause 
phosphorylation of many other kinases, such as Raf kinases and other proteins 
which are involved in NO producing process in macrophages. It is clear that cAMP- 
dependent protein kinases (PKA) regulate the expression of numerous eukaryotic 
genes by agents such as epidermal growth factor and mobilised calcium [Sheng et 
al., 1988].
PGE2 may have a very important role in immune regulation. For instance, PGE2 
inhibits IL-2 and IFN-y production from Thl clones, but not IL-4 and IL-5 
production from Th2 clones [Betz and Fox, 1991]. Addition of IFN-y to 
macrophages results in a marked rise in intracellular pH within a few seconds, 
which depends on an influx of Na+ ions. To date, the enhanced exchange of 
Na+/H+ induced by IFN-y has been most closely linked to the functional effects of 
IFN-y [Prpic et al., 1989]. Some evidence indicates that cAMP levels elevated by 
PGE2 suppress Na+/H+ exchange [Uhing et al., 1992].
i
LPS treatment of macrophages results in the activation of various genes, including 
the genes for TNF-cx, IL-1, IFN-j3, NOS as well as proto-oncogenes like c-fos, c- 
jun, c-fms and c-myc. The activation of these genes is at the transcriptional level, 
and controlled by some DNA-binding transcriptional factors such as NF-kB or AP- 
1 [Lenardo and Baltimore, 1989]. It has been showed that LPS treatment of J774 
cells leads to the activation of the fast-moving (called B l) and slow-moving (called
7'
i:
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B2) NF-kB, and this activation is inhibited by H89, which is a PKA inhibitor, but 
not by H7, which is a PKC inhibitor [Muroi and Suzuki, 1993]. Furthermore, the 
treatment of J774 cells with dibutyryl cAMP, forskolin, cholera toxin and IBMX 
induced the activation of the both slow-moving and fast-moving NF-kB proteins. 
However, there is a difference between the NF-kB activation time points induced 
by cAMP-elevating agents and LPS. Cyclic AMP-elevating agents induce early 
activation of both NF-kB proteins, synchronously, although LPS induce them at 
different time points. The correlation between NF-kB activation and NO production 
in macrophages has not been shown clearly yet. Further studies are required to 
elucidate the mechanism of the effect of the NF-kB activation on NO production.
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CHAPTER 4
THE EFFECTOR MECHANISM OF IL-4 ON 
NITRIC OXIDE SYNTHESIS
106
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IL-4 induces a transient activation of PLC, followed by a delayed sustained cAMP 
elevation, in human B lymphocytes [Finney et al., 1990]. Agents which increase 
intracellular cAMP levels inhibit cytokine production by macrophages. In our early
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.1:
4.1. INTRODUCTION
Several cytokines, including IL-4 [Liew et al., 1991], IL-10 [Cunha et al., 1992; 
Gazzinelli et al., 1992] and transforming growth factor-p [Ding et al., 1990], have 
been shown to inhibit NO production. However, the pathways involved in the 
regulation of NO synthesis have not yet been fully elucidated.
IL-4 is a 20 kDa polypeptide also known as B-cell stimulatory factor-1 (BSF-1) or 
B cell growth factor (BCGF). IL-4 is produced by activated Th2-like cells 
[Mosmann et al., 1986; Swain et al., 1988], and has many actions on a variety of 
cell types. For example, the proliferation of B cells, the stimulation of the growth of 
T cells, mast cells, and macrophage differentiation and activation [Reviewed by 
Farrar et al., 1990]. On the other hand, there are reports suggesting that IL-4 
induces expression of class II major histocompatibility complex molecules on 
resting B cells [Roehm et al, 1984] and that IL-4 induces IgE responses and 
maintains them [Finkelman et al, 1988].
The mechanism of signal transduction by IFN-y is not yet known. However, it was 
found that IFN-y stimulation involved PKC activity in peritoneal macrophages 
[Hamilton et al., 1985]. It has been reported that inhibition of PKC activity, or 
down-regulation of PKC by prolonged incubation of J774 cells with phorbol 
esters, reduces NO production in response to IFN-y and LPS. Furthermore,
I
stimulation of macrophages with these agents results in translocation of PKC to the 
cell membrane [Severn et al., 1992b]. These observations suggest that PKC
activation is essential in the induction of NO production by IFN-y and LPS.
studies, it was shown that prolonged elevation of cAMP levels induced by PGE2 
and IBMX (a phosphodiesterase inhibitor) reduces NO production and iNOS 
activity and expression, but does not inhibit the expression of iNOS mRNA. 
Therefore, increased intracellular cAMP levels in response to IL-4 might effect NO 
production.
Using a murine macrophage cell line, J774, we have investigated the mechanism of 
inhibition of NO production by IL-4. Translocation of PKC is inhibited by IL-4, as 
is PKC activity in cell extracts. Both IL-4 and the PKC inhibitor, Ro31-8220, 
inhibited iNOS gene transcription. The IC5 0  of this compound against PKC 
isolated from rat brain is 20  times and 200  times lower than those against isolated 
protein kinase A (from bovine heart) and Ca^+/calmodulin-dependent protein 
kinase (from rat brain), respectively [Davis et al., 1989].
On the other hand IL-4 did not induce changes in cAMP levels in macrophages. 
These data suggest that IL-4 may act by inhibiting the activation of PKC, which is 
essential in the induction of iNOS gene transcription, and not by inducing cAMP 
generation.
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4.2. RESULTS:
4.2.1. Pretreatm ent of cells with IL-4 is necessary to inhibit NO 
production in response to IFN-y and LPS:
In our experimental model, it is necessary to know by which mechanism IL-4 
inhibits NO production in macrophages. In order to do that, it is necessary to 
investigate the best effective time point for IL-4 treatment in J774 cells. Then, we 
may be able to predict if the effect of IL-4 requires early or late phase events 
compared to the relay of signalling by stimulating agents, like IFN-y and LPS.
The effect of IL-4 (100 U/ml) was investigated in a time response study in J774 
cells. J774 cells were adjusted to 5 x 10^ cells per ml RPMI 1640 medium 
supplemented, as detailed in Chapter 2. IL-4 was used at 18 hrs and 4 hrs before 
stimulation with IFN-y (40 U/ml) and LPS (10 ng/ml), as well as at the same time 
as IFN-y and LPS and 4 hrs after stimulation. Then, cells were incubated at 37°C, 
in a CO2  incubator (5 % CO2 ) for 24 hrs. NO2  was measured in supernatants 
after 24 hrs incubation by using chemiluminescence, as previously described.
It was observed that the best time point to treat the cells with IL-4 is 18 hrs before 
stimulation by IFN-y and LPS, indicating that the inhibitory effect of IL-4 on NO 
production by J774 cells in response to IFN-y and LPS requires early phase events, 
such as activation of constitutively expressed proteins, new protein synthesis or 
consumption of substances, which are required for IFN-y and LPS-induced 
downstream signalling, or that IL-4 requires time to work (p<0.05). Results are 
shown in figure 4.1.
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Figure 4.1: The effect of IL-4 (100 U/ml) at different time points on NO 
production in response to IFN-y (40 U/ml) and LPS (10  ng/ml) in J774 cells. IL-4 
was used at 18 hrs and 4 hrs before stimulation with IFN-y (40 U/ml) and LPS (10 
ng/ml), as well as at the same time as the stimulatory agents and 4 hrs after the 
stimulatory agents. Cells treated with IL-4 and stimulated by IFN-y (40 U/ml) and 
LPS (10  ng/ml) at the same time, were incubated for 24 hrs. N02~ was measured 
in supernatants after 24 hrs incubation of cells by using chemiluminescence, as 
previously described. The means ± SEMs are shown in triplicate samples. Results 
are representative of three separate experiments.
(^: p<0.05, n=3)
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4.2,2. The best inhibitory concentration of IL-4 is 100 U/ml:
In the experimental model used, the finding of the best IL-4 concentration for 
sufficient inhibition of NO production in response to IFN-y and LPS would be 
helpful for future work. The inhibitory effect of IL-4 on NO production, at a variety 
of concentrations, was investigated in J774 cells. Cells were adjusted to 5 x 10^ 
cells in 1 ml RPMI 1640 medium supplemented, as described in Chapter 2. IL-4 
was given to the cells 18 hrs before stimulation. Cells were given IL-4 at a variety 
of concentrations, and were incubated at 37^C, in a CO2 incubator (5 % CO2 ) for 
18 hrs and then stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml). Supernatants 
were measured, after a further 24 hrs incubation of the cells, by 
chemiluminescence, as previously described. As shown in figure 4.2., the most 
efficient concentration of IL-4 that inhibits NO release by macrophages is 100 U/ml 
(p value<0.01). Therefore, in our following experiments, IL-4 will be used at 100 
units per ml.
4.2.3. A monoclonal antibody against the IL-4 receptor neutralises 
the inhibitory effect of IL-4 on NO synthesis by J774 cells:
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It was necessary to evaluate whether the inhibitory effect of IL-4 is specific for IL-4 
itself or is due to nonspecific interactions, such as changes in membrane fluidity. 
The specificity of the inhibitory effect on NO production caused by IL-4, was tested 
by using the monoclonal receptor blocking antibody Ab-IL-4R at a range of 
concentrations (0-20 pg/ml). Anti-IL-4R monoclonal antibody, which is an Ig02aK
class antibody, was supplied by Genzyme. It was reported that 1774 cells have 355 
± 120 IL-4 receptors per cell on their surface [Beckmann et al., 1990], and the 
association and dissociation iy 2 ^ min and 4 hrs, respectively [Lowenthal et al,.
1988a].
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Figure 4.2: The inhibitory effect of IL-4 on NO production, at a variety of 
concentrations, was investigated in J774 cells. IL-4 was used 18 hrs before 
stimulation. Cells were given IL-4 at variety of concentrations and incubated for 18 
hrs before stimulation with IFN-y (40 U/ml) and LPS (10 ng/ml) or LPS (1 p,g/ml) 
alone. Supernatants were measured after a further 24 hrs incubation of the cells by 
chemiluminescence. Controls were obtained from the supernatants of unstimulated 
cells. Results are representative of three separate experiments. The means ± SEMs 
are shown in triplicate samples.
(**: p <0.01, p<0.05, n=3)
112
s
■44
I
was used for the measurement of citrulline produced from L-arginine in 1 hr by 
using the technique detailed in Chapter 2. As shown in Figure 4.4., pretreatment of 
J774 cells with IL-4 results in the reduction of iNOS activity induced by IFN-y and 
LPS (p<0.05). lL-4 alone does not have any effect in resting cells.
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The mAb-lL-4R was used at a range of 0-20 pg/ml. Cells were treated with IL-4 1 
hr after adding mAb-IL-4r and 18 hrs before stimulation with IFN-y and LPS. Cells 
stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml) were incubated for a further 24 
hrs in incubation conditions, as previously described. As a control, an irrelevant 
monoclonal antibody to CD8  (YTS 169 IgG) was used at a concentration between 
0-20 pg/ml (produced by C. O'Donnell of Western Infirmary, Immunology 
department, Glasgow, UK). Supernatants were used for NO2 ” measurement by 
using chemiluminescence. As shown in figure 4.3., the binding of monoclonal Ab- 
1L-4R to IL-4 receptors on the cell surface prevents the inhibition of NO production 
by lL-4 in a dose-dependent manner (p<0.01-0.05). These data indicate that the 
inhibition of NO production in response to the combination of IFN-y and LPS or 
high concentration of LPS alone is due to specific IL-4-mediated signalling in J774
cells. The next step concentrates on the mechanisms employed by IL-4 through the 
IL-4R.
4.2.4, IL-4 inhibits iNOS activity in cells stimulated by IF N -y and 
LPS:
The effect of IL-4 on the iNOS enzyme activity was determined. J774 cells were 
adjusted to 1 x 10^ cells/ml in RPMI medium in 24-well plates (Costar), then 
treated with or without lL-4 (100 U/ml) for 18 hrs before stimulation with IFN-y 
(40 U/ml) and LPS (10 ng/ml). Cells were incubated, as described previously, for a
further 12 hrs. Medium was removed and the cells were washed three times with 
warm PBS, and the cytosol was extracted, as described in Chapter 2. The cytosol
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Figure 4.3; The effect of the IL-4R blocking monoclonal Ab-IL-4R at a range of 
concentrations (0-20 |ig/ml) was assessed for its ability to block lL-4-mediated 
inhibition of NO production in J774 cells. Cells were treated with lL-4 1 hr after 
adding mAb-lL-4R and 18 hrs before stimulation. Cells stimulated by IFN-y (40 
U/ml) and LPS (10 ng/ml) were incubated for a further 24 hrs. As a control, an 
irrelevant monoclonal antibody to CDS (YTS 169 IgG) was used at a variety of 
concentrations (0-20 pg/ml). Supernatants were used for NO2 " measurement by 
chemiluminescence. Results are representative of three separate experiments. The 
means ± SEMs of triplicate samples have been shown.
(^: p<0.05, p<0.01, n=3)
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Figure 4.4: The effect of IL-4 on iNOS activity in resting and stimulated cells by 
IFN-y and LPS. J774 cells were adjusted to 1 x 10^ cells in ml RPMI medium in 
24-well plates (Costar), then treated with or without IL-4 (100 U/ml) for 18 hrs 
before stimulation with IFN-y (40 U/ml) and LPS (10 ng/ml). Cells were 
incubated, for a further 12 hrs. The cytosol was used for measurement of citrulline 
produced from L-arginine in 1 hr by using the technique detailed in Chapter 2. 
Results are representative of three separate experiments, and the means ± SEMs of 
triplicate samples are shown.
(*: p<0.05, n=3) 1
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4 .2 .5 . IFN-y and LPS induce PKC translocation to the 
membrane at two different time points:
The activation of PKC in response to IFN-y and LPS in J774 cells has been 
reported [Severn et al., 1992b], The translocation of some PKC isoforms induced 
by IFN-y and LPS can be easily explored by using phorbol ester binding assays. In 
this study, phorbol dibutyrate (PDBu) was used. Therefore, cells were adjusted to 
2 x 10 /ml in medium and incubated in 96-well plates, as described in Chapter 2. 
Then, cells were stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml) for different 
times. Medium was removed and the cells were washed three times with ice cold 
PBS. Cells were treated with pH]-PDBu (0.6 pCi/ml) for 10 minutes at 37^C. 
pH]-PDBu binding was measured, as detailed in Chapter 2. As shown in Figure
4.5., the stimulation of J774 cells with IFN-y and LPS results in the translocation 
of PKC into membrane at two different time points, 3 minutes and 30 minutes after 
stimulation (p<0.01). Now, we can measure the effect of IL-4 on PKC activation, 
and the translocation induced by IFN-y and LPS can be investigated.
I
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4.2.6. IL-4 inhibits PKC translocation to the cell membrane:
#The exploration of the effect of IL-4 on PKC translocation is a vital step in this 
project to explain the effector mechanisms mediated by IL-4. Therefore, we 
examined the effect of IL-4 on PKC translocation in macrophages. J774 cells were 
incubated in medium at 37^C, as described in Chapter 2. for 18 hours with or 
without IL-4 (100 U/ml), then IFN-y (40 U/ml) and LPS (10 ng/ml) added for a 
further 3 minutes. Then, medium was removed and cells were washed 3 times with 
ice cold PBS buffer (pH:7.4), and the binding of [^H]-PDBu to the cells 
determined, as described in Chapter 2. As expected, stimulation of the cells by 
IFN-y and LPS has markedly increased [^Hj-PDBu binding compared to 
unstimulated cells.
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Figure 4.5: The effect of IFN-y (40 U/ml) and LPS (10 ng/ml) on PKC 
translocation into the plasma membrane in J774 cells. The cells (2 x 10^ cells/well) 
were stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml), and resting cells were 
used as controls. Cells were stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml) at 
different time points (0, 3, 10 and 30 minutes). Medium was removed and cells 
were washed three times with ice cold PBS. Cells were treated with [^H]-PDBu 
(0.6 pCi/ml) for 10 minutes at 37^C. [^H]-PDBu binding was measured, as 
detailed in Chapter 2. The means ± SEMs of triplicate cultures are shown. Results 
are representative of three separate experiments.
(^*: p<0.01, n=3)
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IL-4 reduced binding to both resting and stimulated cells (p<0.01). The binding of 
pH]-PDBu to the cell surface may be due to constitutively membrane bound PKC, 
as J774 cells can proliferate and PKC is known to be involved in this process.
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4.2.7. IL-4 inhibits total PKC activity;
The determination of pH]-PDBu binding to the translocated PKC enzymes acting 
as a receptor on the cell surface may not be sufficient to explain the mechanisms of 
IL-4 action. Because, some isoforms of PKC, like the PKC-^ isoform, may be 
activated, but not translocated in J774 cells, and PKC-^ does not bind PDBu. 
Therefore, a broad specificity PKC assay system was used.
J774 cells were incubated in the presence or absence of IL-4 (100 U/ml) for 18 hrs, 
then stimulated with IFN-y (40 U/ml) and LPS (10 ng/ml) as in the previous 
experiments. Cytosol was extracted, as detailed in Chapter 2. Then, results were 
obtained by using Amersham PKC assay kit system. Cells activated with IFN-y 
and LPS showed a marked rise in PKC activity which was significantly inhibited 
by the pretreatment of cells with IL-4 (p<0.01). The fact that, IL-4 did not inhibit 
PKC activity in resting cells, may be due to the basal activity of PKC, which is 
resistant to the IL-4 treatment. (Figure 4.7).
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Figure 4.6: The effect of IL-4 on PKC translocation to the cell membrane. J774 
cells (3xlCp cells/well) were incubated in medium for 18 hours with or without IL- 
4 (100 U/ml), then IFN-y (40 U/ml) and LPS (10 ng/ml) added for a further 3 
minutes. Then, medium was removed and cells were washed 3 times with ice cold 
PBS buffer (pH:7.4), and the binding of pH]-PDBu to the cells was determined. 
Results are representative of three separate experiments, and the means ± SEMs of 
triplicate samples are shown.
(^^: p<0.01, n=3)
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Figure 4.7: The effect of IL-4 on total PKC activity. J774 cells were incubated in 
the presence or absence of IL-4 (100 U/ml) for 18 hrs, then stimulated with IFN-y 
(40 U/ml) and LPS (10 ng/ml). Total protein kinase activity was measured in 
detergent extracts as described in Chapter 2. Results are representative of three 
separate experiments, and the means ± SDs of duplicated samples are shown.
(**: p<0 .0 1 . n=2 )
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4.2.8. iNOS gene transcription is inhibited by IL-4:
In order to determine the level at which IL-4 inhibits NO production, we 
investigated the effect of IL-4 on iNOS gene transcription. Cells were incubated for 
18 hours, with or without IL-4, then incubated for 6  hours with IFN-y and LPS, or 
without stimuli. Total RNA was then extracted, and reverse transcription and 
PCR were perfomied. Preliminary experiments had established that the peak iNOS 
mRNA expression is between 3-6 hrs after stimulation in the present system (G.J. 
Feng, personal communication). Transcription of the iNOS gene was induced by 
IFN-y and LPS, and this was inhibited by pre-incubation with IL-4. iNOS mRNA 
was not detected in cells not exposed to IFN-y and LPS, regardless of whether IL-4 
was present (Figure 4.8). These data indicate that IL-4 regulates NO production by 
altering iNOS mRNA expression in response to IFN-y and LPS by J774 cells.
4.2.9. iNOS gene transcription is reduced by a PKC inhibitor:
The involvement of PKC activation in NO production is still to be determined, in 
order to do this, the selective PKC inhibitor, Ro31-8220 was used. If the inhibition 
of NO production by IL-4 is via the inhibition of PKC translocation and activation, 
it would be predicted that inhibition of PKC activity by other means would also 
inhibit the iNOS gene transcription. The effect of Ro31-8220 on iNOS mRNA 
levels was therefore investigated. Results shown in Figure 4.9. demonstrate that the 
transcription of iNOS by J774 cells activated with IFN-y and LPS was inhibited by 
the presence of Ro31-8220 at 50 pM, a concentration not cytotoxic to the J774 cells 
[Severn et al., 1992b; Davis et al., 1989].
■ iiv ;
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Lane 1: IFN-y (40 U/ml) and LPS (10  ng/ml)
Lane 2: IFN-y (40 U/ml) and LPS (10 ng/ml) + IL-4 (100 U/ml)
Lane 3: IL-4 (100 U/ml) alone 
Lane 4: Resting Cells (Controls)
Figure 4.8: The effect of IL-4 on iNOS gene transcription. Cells were incubated 
for 18 hours, with or without IL-4, then incubated for 6  hours with IFN-y and 
LPS, or without stimuli. iNOS gene transcription was induced by IFN-y (40 U/ml) 
and LPS (10 ng/ml), and this was inhibited by pre-incubation with IL-4 (100 
U/ml). Controls show p-actin bands in J774 cells. Results are representative of 
three separate experiments.
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Lane 1: IFN-y (40 U/ml) + LPS (10 ng/ml)
Lane 2: IFN-y (40 U/ml) + LPS (10 ng/ml) + Ro-31-8220 (50 i^M)
Lane 3: Ro-31-8220 (50 p,M) alone 
Lane 4: Resting cells (Control)
Figure 4.9: The effect of the selective PKC inhibitor, Ro31-8220, on iNOS gene 
transcription. Results shown in Figure 4.9. demonstrate that the transcription of 
iNOS by J774 cells activated with IFN-y (40 U/ml) and LPS (10 ng/ml) was 
inhibited by the presence of Ro31-8220 (50 pM) added half an hour before 
stimulation with IFN-y and LPS. Results are representative of three separate 
experiments.
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4.2.10. IL-4 does not increase cAMP levels in J774 cells:
In B cells, IL-4 treatment causes an intracellular elevation of cAMR T he 
investigation of intracellular cAMP responses to IL-4 treatment is necessary to 
clarify the regulatory function of IL-4 in J774 cells. The effect of IL-4 (100 U/ml) 
on cAMP levels in J774 cells was therefore investigated.
Cells were adjusted to 5 x 10 cells in 24-well plates and treated with reagents for 
different time points. PGE2  (10"^ M) was used to stimulate cAMP production in 
J774 cells for 15 min as a positive control. After removing the medium, cells were 
washed three times with ice cold PBS. Cytosol was extracted for cAMP 
measurement by using an Amersham radio-labelled binding kit system, as detailed 
in Chapter 2.
No increase in cAMP concentrations was detected in cells incubated with IL-4 (100 
U/ml) (Table 4.1). In control cultures, PGE2  induced a large increase in cAMP 
levels. These results presented here demonstrate that IL-4 does not regulate NO 
production by inducing intracellulai' cAMP levels in J774 cells.
A-
-
a
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3
124
Table 4.1: IL-4 (100 U/ml) does not cause cAMP elevation in J774 cells. Cells 
were adjusted to 5 x lO^/ml in 24-well plates and treated with reagents for different 
time points. PGE2  (10"^ M) was used to activate J774 cells for 15 min as a control.
concentrations was detected in cells incubated with IL-4 (100 U/ml). In positive 
control cultures, PGE2  induced a large increase in cAMP levels. Basal cAMP 
concentrations were obtained from resting cells. Results are representative of three 
separate experiments. The means and standard deviations of triplicate cultures are 
shown (n=3)
cAM P (pm ol/10^ cells)
Substance 15 min 2  hrs 6  hrs 24 hrs 48 hrs
IL-4 <1 <1 <1 <1 <1
PGE2 80.00 ± 5.00 -------- — -------- —
Controls <1 <1 <1 <1 <1
I
IL-4 (100 U/ml) was used at different time points. No increase in cAMP ■if;
Î
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4.3. DISCUSSION:
It is generally recognised that the balance between Thl-like and Th2-like cells 
determines the outcome of a number of infectious and autoimmune diseases [Liew,
1989; Sher and Coffman, 1992; Romagnani, 1991; Mason and Fowell, 1992;
Bloom et al., 1992]. They do so via their characteristic cytokines. One mechanism 
is as follows: T hl cells produce IFN-y which, together with other molecules such ' t
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as LPS and T N F a, activates macrophages to produce NO which mediates 
cytopathic and microbicidal effects [Nathan and Hibbs, 1991; Hibbs et al., 1990; 
Liew and Cox, 1991; Green et al., 1990]. Th2-like cells, on the other hand, 
produce IL-4 and IL-10 which inhibit the synthesis of NO by macrophages [Liew et 
al., 1991; Cunha et al., 1992; Gazzinelli et al., 1992]. The mechanism of 
interaction of IFN-y and IL-4 in the regulation of NO synthesis is unknown. This
is clearly an important area, as an understanding of this mechanism may lead to
.effective control of this important biological mediator and therapy for several
important diseases. Data presented here contribute to the understanding of this 
mechanism.
It has been previously demonstrated that the activation of PKC is required for the 
induction of macrophage iNOS gene transcription [Severn et al., 1992b]. In this 
study, IL-4 inhibits the synthesis of NO via the blocking of the PKC activation 
pathway. This is supported by our finding that transcription of the iNOS gene was 
inhibited by IL-4 as well as the PKC inhibitor, Ro31-8220. It has been proposed 
that PKC-epsilon (PKC-e) is the predominant isoform in the macrophages activated 
with IFN-y and LPS [Sands et al., 1994a]. It should be noted that IL-4 inhibits NO 
synthesis only when macrophages are pretreated with this cytokine before activation 
with IFN-y and LPS [Liew et al., 1991]. Inhibition of PKC activation also required 
incubation with IL-4 for several hours before stimulation. IL-4 did not effect an 
immediate reduction in [3h ]-PDBu binding to whole cells, and addition of IL-4 to
the cells at the same time as or after IFN-y and LPS did not prevent an increase in 
PDBu binding [Sands et al., 1994a]. In human monocytes, IL-4 induces 
translocation of PKC to the nucleus, resulting in reduced activity in the cytoplasm 
[Arruda and Ho, 1992]. Thus the mechanism of the interaction of IL-4 and IFN-y 
in the control of NO synthesis is complex and factors other than PKC are probably 
involved. However, this change occurs within minutes, and it is unlikely that the 
same process is occurring in J774 cells. Another recent report has described 
inhibition of PKC by IL-4 in lymphocytes [Hart et al., 1989b]. It is not yet clear 
how IL-4 inhibits PKC activation. It may inhibit generation of DAG, which is the 
physiological activators of PKC [Nishizuka, 1992], by acting on a phospholipase.
IL-4 has other inhibitory effects on macrophages, reducing the production of TNF- 
a , IL-1 and prostaglandin E2  [Politis and Vogel, 1990]. Several macrophage 
activities have been shown to be dependent on PKC activation [Kawanishi, 1993]. 
The blocking of the PKC activation pathway by IL-4 may, therefore, explain its 
general inhibitory effects on macrophages. A report has also described inhibition of 
PKC by IL-4 in B lymphocytes [Harnett et al., 1991]. Additionally, In B cells, IL- 
4-mediated regulation of gene expression is controlled by the Janus family o f 
kinases Jakl and Jak3, which mediate tyrosine phosphorylation of signal- 
transducers and activators of transcription (STATs), such as the IL-4 nuclear 
activated factor (IL-4 NAF) and the signal-transducing factor of IL-4 (STF-IL-4) 
[Keegan et al., 1994; Johnston et al., 1994; Witthuhn et al., 1994].
An increase in intracellulai' cAMP concentration as a mechanism of inhibition of NO
3production by IL-4 has been excluded. In human B cells, IL-4 does induce a 
delayed rise in cAMP [Finney et al., 1990]. This was not detected in J774 cells. 
However, differences between the signalling pathways of human and murine IL-4 
have been reported [McGarvie and Cushley, 1989]. Additionally, some other 
differences in iNOS regulation can be observed between different types of
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macrophage. For instance, IL-4 was reported to strongly reduce iNOS mRNA at 
24-72 hrs post stimulation, but not 4-6 hrs after exposure to IFN-y and LPS in 
primaiy peritoneal mouse macrophages [Bogdan et al., 1994].
In this study, Data suggest that IL-4 reduces NO production and iNOS mRNA 
synthesis by inhibiting PKC, but not inducing intracellular cAMP levels. The 
monoclonal Ab-IL-4R was used to block the effect of IL-4 on macrophages.
In conclusion, we have further defined the role of PKC in the induction of NO 
production by murine macrophages, showing its activation to be essential for iNOS 
gene transcription. We have also partly elucidated the mechanism by which IL-4 
inhibits NO production. The inhibition of PKC activation by IL-4 may explain its 
other effects on macrophages.
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CHAPTER 5
THE EFFECT OF G-PRQTEIN MODIFIERS. PLATELET 
ACTIVATING FACTOR AND PHOSHOLIPASE A^ ACTIVITY ON
NO SYNTHESIS
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5.1. INTRODUCTION:
It has been reported that cAMP-elevating agents, such as PGE2  and 8 -Br-cAMP, 
when applied together with the nonspecific PDE inhibitor isobutyl-methylxanthine 
(IBMX), causes a sustained elevation of intracellular cAMP and inhibits NO 
production in macrophages stimulated by IFN-y and LPS [Bulut et al, 1993]. 
Platelet activating factor, which is a potent ether linked phosphocholine (l-alkyl-2- 
acetylglycerophosphocholine) [Prpic et al., 1988], is a secretory product of 
activated macrophages, like Prostaglandin E2  (PGE2 ) [Adams and Hamilton, 
1992]. A high affinity receptor on macrophages for PAF has been described, and 
binding of PAF to macrophages results in the rapid breakdown of 
polyphosphoinositides, resulting in di acyl glycerol production and activation of 
protein kinase C [Rosen et al, 1989]. Moreover, like PGE2 , PAF induces an 
elevation of intracellular cAMP levels. Therefore, it might inhibit NO production via 
the elevation of cAMP in cells.
As indicated in Chapter 4, IL-4 reduces NO and iNOS message synthesis by 
inhibiting PKC activity [Sands et al, 1994a]. It was observed that 
phosphatidylcholine-specific PLC (PC-PLC), which causes DAG release via 
hydrolysis of membrane bound phosphatidylcholine, is involved in PKC activation 
in macrophages, and IL-4 acts by inhibiting PC-PLC [Sands et al., 1994b]. On the 
other hand, phospholipase A2  (PLA 2 ) comprises a family of enzymes that 
hydrolyse the acyl bond at the sn-2  position of phospholipids to generate free fatty 
acid and lysophospholipids. In other word, PL A 2 activity selectively cleaves 
arachidonyl phosphatidylcholine to initiate eicosanoid and PAF production in 
macrophages [Suga et a l ,  1990]. The free arachidonic acid generated by PLA2  
activity is converted to a large number of products by cyclooxygenases, 
lipoxygenases and monooxygenases [reviewed by Bonventre, 1992], and have 
both intercellular and intracellular messenger effects. PL A 2  has been identified in 
the cytosol of U937 cells [Clark et al, 1991], RAW 264.7 cells [Channon and
I;
130
...i
Leslie, 1990], the P388Di macrophage-like cell line [Lister et al., 1989], rat brain 
[Yoshihara and Watanebe, 1990], kidney [Gronich et al, 1990], and platelets 
[Takayama et al., 1991]. The presence of the enzyme in U937 cells, brain,
ki.':kidney, platelets, RAW 264.7 and P388Di macrophage cell lines, would strongly 
suggest that this enzyme is ubiquitous in cells of the reticulo-endothelial system and
PL A 2  mRNA expression induced by forskolin in cultured smooth muscle cells 
[Nakano et al., 1990]. A synthetic glucocorticoid, dexamethasone, which inhibits 
PLA2  activity, leads to reduced amounts of NO production in vascular endothelial 
cells and hepatocytes [Radomski et al., 1990, Geller et al., 1993].
Therefore, an investigation of the effects of PAF and PLA2  inhibitors on NO 
production in macrophages would be useful for understanding the mechanism, 
which is involved in NO production.
Meanwhile, Studies in neutrophils have shown that the formyl peptide, 
formylmethionylleucylphenylalanine (fMetLeuPhe)-mediated release of arachidonic 
acid is sensitive to inhibition by pertussis toxin treatment [Okajima and Ui, 1984].
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c.is also likely to be present in the J774 macrophage cell-line. Early studies had 
shown that Ca^+Z diacyl glycerol may be the main regulators of PLA2  [Billah and 
Siegel, 1987, and Volpi et al., 1985], both products of the phospholipase C 
pathway. Furthermore, the PLA2  activity may also be altered by the following 
events: intracellular pH change, protein kinase activation, heterotrimeric guanine 
nucleotide-binding regulatory proteins (G-proteins) activation, inhibitory proteins 
of PLA2 , such as lipocortins, and PLA2  activating proteins (PLAP) induced by 
TNF and leukotriene D4  (LTD4 ), metabolic product inhibition, and transcriptional 
control by forskolin, which is an adenylyl cyclase activator, glucocorticoids and 
TNF [reviewed by Bonventre, 1992; Cockroft, 1992]. For instance, IL-1, TNF-a, 
forskolin and LPS enhance the secretion of PLA2  in rat mesangial cells [Schalkwijk 
et al., 1991], and it was also reported that glucocorticoids inhibit the increase of
I .
Moreover, it has been demonstrated that PLA2  activity can be induced by p/y 
subunits of TD l, which is a G-protein, in bovine rod outer segments [Jelsema and 
Axelrod, 1987]. This evidence shows that PLA2  activation can be in a G-protein- 
dependent manner. Therefore, it is necessary to investigate the relationship of G- 
proteins to LPS and cytokine receptors, such as IFN-y and IL-4.
Since well-characterised covalent modifications of G-proteins are the ADP- 
ribosylation reactions carried out by toxins produced by V. cholerae and B. 
pertussis [Gill and Meren, 1978; Cassel and Pfeuffer, 1978; Moss and Vaughan, 
1977; Katada and Ui, 1982]. In this study we have examined the effects of the G- 
protein modifiers. Pertussis toxin (Ptx) and Cholera toxin (Ctx), PL A 2 activity and 
its product PAF on NO production.
Pertussis toxin (Ptx), produced by Bordetella pertussis, is composed of two 
subunits. The B oligomer is responsible for the binding of the toxin to the cell 
membrane, whereas the A oligomer catalyses ADP-ribosylation and inactivation of 
GTP binding proteins coupling membrane receptors to either adenylate cyclase, 
phospholipase-C, phospholipase A2 , Ca^+ or K"^  channels [reviewed by Stryer 
and Bourne, 1986; Gilman, 1987; Spiegel, 1988; Dunlap et al, 1987; Exton, 
1988]. In contrast, early studies have shown that Ptx induces an early increase in 
intracellular [Ca^+] resulting from an influx across the plasma membrane and 
release of Ca^+ from intracellular stores in Jurkat T-cells, and activates a 
phospholipase C-dependent pathway [Modesto et al., 1991; Gray et al., 1989]. It 
was reported that Ptx enhances LPS-induced TNF-a production while at the same 
time inhibits LPS-dependent NO production, and these effects are correlated with 
Ptx-mediated ADP-ribosylation of a 41-kDa protein [Zhang and Morrison, 1993].
Cholera toxin (Ctx) is composed of an A subunit and multiple B subunits. The A 
subunit induces ADP ribosylation, with consequent activation, of the a  subunit of
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does not involve G-protein-mediated signalling mechanisms in J774 cells.
the stimulatory G-protein, Ggcx. This can result in the activation of adenylyl 
cyclase in most cells [Mathews and von Holde, 1992; Cassel and Pfeuffer, 1978; 
Milligan, 1989], and Ctx also causes activation of dihydropyridine-sensitive 
Ca^+ channels [Milligan, 1989]. As detailed in Chapter 1, Ctx, can activate Golf, 
which is found in olfactory sensory neurones, as well as, TD l and TD2, which are 
distributed in Rod outer and inner segments, respectively [Reviewed by Milligan 
and Wakelam, 1989]. The B subunits have high affinity for the ganglioside GM%, 
which is thought to be the membrane receptor for Ctx [Sommermeyer et al., 1989].
In this chapter, the effects of cholera and pertussis toxins have been investigated to
show if G-protein activation regulates the activity of downstream effector proteins 
involved in NO production. Pertussis toxin does not alter NO production in 
response to IFN-y and LPS or LPS alone. However, cholera toxin inhibits NO 
produced in response to high doses of LPS alone or IFN-y and a low dose of LPS 
together in J774 cells in a dose-dependent manner. Unfortunately, this effect was 
found to be nonspecific for cholera toxin, because the toxin solution contains 
sodium azide at a concentration of 0,15 mM. Data presented here suggests that the a
downstream signals from the ligand-receptor complex to the nucleus to produce NO
Meanwhile, PAF does not affect NO production by the J774 macrophage-like cell 
line. Having found PAF does not affect NO production, some PLA2  inhibitors, 
such as 4-bromophenacyl bromide (4-BPB), 4-4-octadecyl-4-oxobenzene butenoic 
acid (OBAA) [Madi et al., 1991] and dexamethasone were used to see, if PLA2  
activity is involved in NO production in J774 cells. In this chapter, data suggest that 
PLA2  activity is not involved in the NO production in response to IFN-y and low 
doses of LPS in J774 cells. :3
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5.2. RESULTS:
5.2.1. PAF does not alter NO production in response to IFN-y and 
LPS in J774 cells:
PAF is a useful molecule to investigate NO production, because of its LPS 
m im icking effects, like the induction of cAM P genera tion  and 
polyphosphoinositides hydrolysis, DAG generation and PKC activation in 
macrophages [Nibbering et a l ,  1992; Adams and Hamilton, 1992]. In addition, 
PAF may induce arachidonic acid hydrolysis products. Because of this, we used 
PAF to start the exploration of PLA2 -mediated signalling events.
J774 cells, 5 x 10^ /ml in RPMI 1640 medium, were cultured in 96-well plates. 
Cells were pretreated with a variety of concentrations of PAF in the range of 10"^- 
10"!^ M. 30 min after adding PAF, cells were stimulated by IFN-y (40 U/ml) and a 
low concentration of LPS (10 ng/ml) or with LPS alone (1 p,g/ml), then incubated 
at 3 7 °C for 24 hrs. N02~ levels were measured by chemiluminescence in 
supernatants. Stimulation of J774 cells with IFN-y (40 U/ml) and a low 
concentration of LPS (10 ng/ml) or with LPS alone (1 pg/ml) induced the 
production of NO. Nitric oxide production was not affected by PAF alone. In cells 
treated with PAF and stimulated with IFN-y and LPS, there was no significant 
inhibition of NO production (Figure 5.1). Because PAF (100 mM) was dissolved 
in chloroform, controls were carried out, and the results were not affected by 
chloroform (maximum concentration 0.1 % v/v).
Cell viability was examined by trypan blue exclusion and evaluated as normal in 
cells treated with PAF (>96%). Moreover, cells treated with PAF were able to 
adhere and spread in a similar manner to untreated cells, and the general 
morphology also appeal ed normal
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Figure 5.1: The effect of PAF at a variety of concentrations on NO production in 
response to IFN-y and LPS in J774 cells. The effect of PAF at a variety o f 
concentrations (10"^-10"^^ M) on NO production in resting and stimulated cells
cwas investigated. J774 cells, 5 x 10 , were cultured in 96-well plates. Cells were 
pretreated with a variety of concentrations of PAF. 30 min after adding PAF, cells 
were stimulated by IFN-y (40 U/ml) and a low concentration of LPS (10 ng/ml) or 
with LPS alone (1 pg/ml), then incubated for 24 hrs. N 02“ levels were measured 
by chemiluminescence in the supernatants. Since PAF was dissolved in chloroform 
(100 mM), controls carried out showed that the results were not affected by 
chloroform (max. 0 .1%  v/v). Control unstimulated cells did not produce NO in 
response to PAF. Results are representative of three separate experiments. The 
means ± SEMs of triplicate cultures are shown. (n=3)
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5.2.2. PAF does not alter NO production in response to various 
concentrations of LPS in J774 cells:
In the previous experiment, PAF was used with a high concentration of LPS alone 
(I pg/ml). This concentration of LPS alone is sufficient to induce NO production.
If there is a common pathway used by both PAF and LPS, PAF may cause delayed 
events, consequently, some required factors may have been consumed by LPS- 
mediated signalling. For instance, LPS induces a twofold to threefold rise in the 
intracellular cAMP levels in the presence of IBMX in resident macrophages, as 
PAF elevates the intracellular cAMP concentrations in macrophages [Nibbering et 
al., 1992; Adams and Hamilton, 1992]. Meanwhile, The effects of LPS on 
polyphosphoinositide hydrolysis can be mimicked by PAF in peritoneal 
macrophages [Prpic et al., 1988]. Therefore, the effect of PAF on NO production 
induced by a variety of concentrations of LPS alone was assessed. J774 cells, 5 x 
10^ /ml in RPMI 1640 medium, were cultured in 96-well plates. Thirty minutes 
after adding PAF (1 fxM), cells were stimulated with a variety of concentrations of 
LPS, then incubated for 24 hrs at 37°C. NO2 " levels were measured by '
chemiluminescence in supernatants. Stimulation of J774 cells with LPS, at the 
range of 10 ng-1 p,g/ml, induced the production of NO. Production of NO was not 
affected by PAF (pM), and PAF alone and medium alone controls did not produce 
any NO in the supernatants. No effect of the chloroform carrier was observed 
(Figure 5.2).
Cell viability was examined by trypan blue exclusion in cells treated with PAF
. .(>97%). Moreover, cells treated with PAF were able to adhere and spread in a 
similar manner to untreated cells, and the general morphology appeared also 
normal.
I
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Figure 5.2: The effect of PAF on NO production in response to LPS at a variety 
of concentrations in the J774 macrophage-like cell line. J774 cells were cultured in 
96-well plates. 30 min after adding PAF (1 pM), cells were stimulated by variety 
concentrations of LPS (10 ng-1 pg), then incubated for 24 hrs. NO2 '  levels in the 
supernatants were measured by chemiluminescence. Controls were obtained from 
unstimulated resting cells (medium alone). Results are representative of three 
separate experiments. The means ± SEMs of triplicate cultures are shown. (n=3)
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t5.2,3. NO production was not influenced by PAF pretreatm ent at 
different time points in J774 cells:
There is a possibility that J774 cells might require pretreatment with PAF to 
influence NO production. In order to investigate whether PAF requires time to alter 
NO production, the following experiment was performed. J774 cells, 5 x 10^ /ml 
in RPMI 1640 medium, were cultured in 96-well plates. Having added PAF (10"^ 
M) to the wells at different time points (-18 hrs, -4 hrs, -1 hr and 0), cells were 
stimulated by IFN-y (40 U/ml) and 10 ng/ml LPS , then incubated for a further 24 
hrs at 37° C. NO2 " levels were measured by chemiluminescence in supernatants. 
Because PAF was dissolved in chloroform (100 mM), required controls were 
carried out, and results were not affected by chloroform (max. 0.1  % v/v).
As shown in Figure 5.3., stimulation of J774 cells with IFN-y and a low  
concentration of LPS (10 ng/ml) induced the production of NO. However, in 
stimulated and PAF treated cells, there was no significant influence on NO 
production at any time point.
These data suggest that PAF-mediated signalling is not involved NO production in 
J774 cells.
5.2.4. The PLA2 inhibitor, 4-4-octadecyl"4-oxo-benzeiie b u ten o ic
acid , inh ib its NO production in response to IFN-y and lo w
concentration LPS by a cytotoxic mechanism on J774 cells:
'il
,Having found that PAF does not affect NO production, some PLA% inhibitors, 
such as 4-bromophenacyl bromide (4-BPB), 4-4-octadecyl-4-oxobenzene butenoic 
acid (OBAA) and dexamethasone were used to investigate whether PLA2  activity is
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F igure  5.3: The effect of PAF added to cells at different time points 
prestimulation with IFN-y and LPS on NO production in J774 cells. J774 cells 
were cultured in 96-well plates. PAF (10“^  M) was added to the wells at different 
time points (-18, -4, -1 and 0 hrs) prestimulation, and cells were stimulated by 
IFN-y (40 U/ml) and 10 ng/ml LPS, then incubated for a further 24 hrs. Controls 
show NO2 " levels in untreated well supernatants. NO2 '  levels in the supernatants 
were measured by chemiluminescence. Results are representative of three separate 
experiments. The means ± SEMs of triplicate cultures are shown. (n=3)
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involved in NO production in J774 cells. So that, the function of PLA2 -mediated 
signalling may be eliminated. Again, J774 cells, 5 x 10^ /ml in RPMI 1640 
medium, were cultured in 96-well plates. 30 min after adding OOBA at a variety of 
concentrations, cells were stimulated by IFN-y (20 U/ml) and 10 ng/ml LPS, for 24 
hrs at 37°C. NO2 " levels in the supernatants were measured by the Griess 
reaction, as detailed in Chapter 2 . The PLA2  inhibitor OOBA was dissolved in 
DMSO (10 mM). Controls, using DMSO (0.1 % v/v). were carried out, and the 
results were not affected.
Stimulation of J774 cells with IFN-y (20 U/ml) and 10 ng/ml LPS induced the 
production of NO. Production of NO was inhibited by OOBA in a dose-dependent 
manner. However, there was a correlation between its toxic effect and NO 
inhibition (Figure 5.4.a).
Cell viability was examined by trypan blue exclusion in cells treated with OOBA. 
The coirelation between NO production and cell viability in cells treated with OOBA 
and stimulated by IFN-y (20 U/ml) and 10 ng/ml LPS is presented in figure 5.4.b.
5.2.5. The PLÂ2 inhibitor, 4-bromophenacyl bromide (4-BPB), does 
not affect NO production in response to IFN-y and LPS at 
noncytotoxic concentrations in J774 ceils:
Since OOBA is a toxic substance for cells, another structurally unrelated PLA2  
inhibitor 4-bromophenacyl bromide (4-BPB) was used to see if PLA2  activity is 
involved in NO production in J774 cells. J774 cells, 5 x 10^ /ml in RPMI 1640 
medium, were cultured in 96-well plates. 30 min after adding 4-BPB at a variety of 
concentrations, cells were stimulated by IFN-y (20 U/ml) and a low concentration 
of LPS (10 ng/ml), then incubated at 37°C for 24 hrs. NO2 " levels were measured
140
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Figure 5.4.a; The effect of the PLA2  inhibitor, 4“4-octadecyl-4-oxo-benzene 
butenoic acid, on NO production in response to IFN-y and LPS in J774 cell line. 
1774 cells were cultured in 96-well plates. 30 min after adding OOBA at a variety 
of concentrations (10"^-10"^ M), cells were stimulated by IFN-y (20 U/ml) and 10 
ng/ml LPS, then incubated for 24 hrs. NO2 " levels in the supernatants were 
measured by the Griess reaction. OOBA was dissolved in DMSO (10 mM), 
required controls were carried out, and results were not affected by DMSO (max. 
0.1 % v/v). Results are representative of three separate experiments carried out. The 
means ± SEMs of triplicate cultures are shown, (n-3)
Figure 5.4.b: The correlation between cell toxicity and NO production in cells
'treated with OOBA. Cell viability was examined by trypan blue exclusion in cells 
treated with OOBA. The coiTelation between NO production and cell viability in 
cells treated with OOBA and stimulated by IFN-y (20 U/ml) and a low 
concentration of LPS (10 ng/ml) is shown. The data obtained in figure 5.4. b. are 
used here to display the fact that OOBA inhibits NO production by simply killing 
cells (r value, the correlation coefficiency=0.931). Results are representative of 
three separate experiments. (n=3)
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by the Griess reaction in supernatants, as detailed in Chapter 2. Because 4-BPB 
was dissolved in DMSO, controls were carried out, using DMSO (0.1 % v/v), 
showing that DMSO does not affect the cells. Stimulation of J774 cells with IFN-y 
(20 U/ml) and 10 ng/ml LPS induced the production of NO. Production of NO 
was not inhibited by 4-BPB at noncytotoxic concentrations (Figure 5.5). 
Nevertheless, When 4-BPB was used at concentrations in excess of 1 pM, the cell 
viability was diminished.
Cell viability was examined by trypan blue exclusion in cells treated with 4-BPB 
and the values were indicated where required in Figure 5.5.
Data presented here demonstrate that PLA2  may not be involved the signalling that 
leads to NO production in J774 cells.
5.2.6. Dexamethasone does not affect NO production in response to  
IFN-y and LPS:
Dexamethasone is a very well known PLA2  inhibitor, used as a treatment in many 
aspects of medicine. In order to firm up the evidence that PLA2  is not involved in 
NO production, an inhibitor irreleated to OOBA, dexamethasone was used.
Dexamethasone has been reported to inhibit NO production in cells expressing 
iNOS. J774 cells, 5 x 10^ /ml in RPMI 1640 medium, were cultured in 96-well 
plates, and 30 min after adding dexamethasone at a variety of concentrations, cells 
were stimulated by IFN-y (20 U/ml) and 10 ng/ml LPS, then incubated at 37^C for 
24 hrs. NO2 " levels were measured in the supernatants by the Griess reaction, as 
detailed in Chapter 2. Because dexamethasone is dissolved in chloroform (10 mM), 
controls were carried out, and the results were not affected by chloroform (max. 1 
% v/v).
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Figure 5.5: The effect of the PLA2  inhibitor, 4-bromophenacyl bromide (4- 
BPB), at non-cytotoxic concentrations, on NO production in response to IFN-y and 
LPS in the J774 cell line. J774 cells were cultured in 96-well plates. 30 min after 
adding 4-BPB at a variety of concentrations, cells were stimulated by IFN-y (20 
U/ml) and LPS (10 ng/ml), then incubated for 24 hrs. NO2 " levels in the 
supernatants were measured by the Griess reaction. Because 4-BPB was dissolved 
in DMSO (100 mM), required controls were carried out. When 4-BPB was used at 
concentrations in excess of 1 pM, the cell viability was significantly diminished. 
Cell viability was examined by trypan blue exclusion in cells treated with 4-BPB. 
Results are representative of three separate experiments. The means ± SEMs of 
triplicate cultures are shown. (n=3)
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Stimulation of J774 cells with IFN-y (20  U/ml) and 10 ng/ml LPS induced the 
production of NO. Production of NO was inhibited by dexamethasone at 100 pM.
(Figure 5.6). However, it was not found consistent and reproducible.
Cell viability was examined by trypan blue exclusion and evaluated as normal in !
cells treated with dexamethasone. Moreover, cells treated with dexamethasone were 
able to adhere and spread in a similar manner to untreated cells, and the general 
morphology appeared also normal.
5.2.7. Cholera toxin does not affect NO production in response to 
IFN-y and LPS in the J774 cell-line:
In order to investigate whether there is a role of G-proteins in NO production, 
cholera toxin, which activates Gg, was used as a G-protein modifier. Therefore,
J774 cells, 5 x 10^ /ml in RPMI 1640 medium, were cultured in 96-well plates. 
Thirty minutes after adding cholera toxin (Ctx) at a variety of concentrations (1-100
pg/ml), dissolved in the same medium, cells were stimulated by IFN-y (40 U/ml) 
and LPS (10 ng/ml), then incubated at 37®C for 24 hrs. N O 2 '  levels were 
measured by the Griess reaction in supernatants, as detailed in Chapter 2.
i:
Stimulation of J774 cells with IFN-y (20 U/ml) and 10 ng/ml of LPS induced the 
production of NO. Production of NO was inhibited by Ctx in a dose-dependent 
manner. Unfortunately, this affect was found to be nonspecific for cholera toxin, 
because the toxin solution contains 0.15 mM sodium azide. Sodium azide controls 
gave the same level of inhibition when applied alone in stimulated cells. On the
1:
Other hand, the acceptable concentrations of cholera toxin (500 ng-1 pg/m l) 
according to the literature, using the cell systems did not effect NO production.
(Figure 5.7.a). Cell viability was checked out by using trypan blue dye exclusion 
and determined as normal (>95%). In addition, glucose uptake was used to
evaluate cytotoxic effect of Ctx and sodium Azide.
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Figure 5.6: The effect of dexamethasone on NO production in response to IFN-y 
and LPS. J774 cells were cultured in 96-well plates. 30 min after adding 
dexamethasone at a variety of concentrations, cells were stimulated by IFN-y (20 
U/ml) and LPS (10 ng/ml), then incubated for 24 hrs. NO2 '  levels in the 
supernatants were measured by the Griess reaction.
Because dexamethasone is dissolved in chloroform (10 mM), controls were carried 
out, and data obtained showed no effect of chloroform (maximum concentration, 1 
% v/v) on NO production. The negative controls were obtained from resting cell 
supernatants. Results are representative of three separate experiments. The means ± 
SEMs of triplicate cultures are shown. (n=3)
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Cells were adjusted to a density of IxlO^ cells/well in 1 ml RPMI 1640 medium. 
Cells were treated with 2 pCi/ml pH]-glucose and in RPMI 1640 medium. Then 
test medium (1 ml) containing substances, IFN-y, LPS, Ctx and sodium azide, was 
added. Cells were treated with IFN-y and LPS, Ctx with and without stimulation. 
Untreated cells were used as negative controls, and sodium azide treated wells 
were used as positive controls. The uptake of pH]-glucose was presented as CPM 
values for each group, as detailed in Chapter 2. (Figure 5.7.b).
Cells treated with sodium azide and Ctx showed a low level of glucose uptake 
compaied to resting cells. However, the same level of inhibition in glucose uptake 
has been observed in cells stimulated with IFN-y and LPS. This may be due to the 
toxic effect of NO produced in response to IFN-y and LPS by macrophages.
5.2.8. Cholera toxin treatm ent of J774 cells results in sustained  
intracellular cAMP elevation:
Cholera toxin is an enzyme that catalyses the transfer of ADP ribose from 
intracellular NAD"^ to the a  subunit of the Gg-protein. This causes intracellular 
cAMP generation induced by adenylyl cyclase [Lai, 1980]. Therefore, the effect of 
Ctx on intracellular cAMP levels was assessed, using 50 pg/ml Ctx. Cells were 
treated with Ctx at 37^C for 15 minutes, 8  and 24 hrs. Cytoplasm was extracted, 
as detailed in Chapter 2, and intracellular cAMP levels were determined by using 
Amersham kit system.
Results are shown as pmol/10^ cells in table 5.1. Ctx caused sustained intracellular 
cAMP elevation, and untreated control cells did not produce cAMP.
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Figure 5.7.a: The effect of cholera toxin on NO production in response to IFN-y 
and LPS on the J774 cell-line. J774 cells were cultured in 96-well plates. 30 min 
after adding cholera toxin (Ctx) at a variety of concentrations (1-100 [xg/ml), cells 
were stimulated by IFN-y (40 U/ml) and LPS (10 ng/ml), then incubated for 24 
hrs. NO2 '  levels were measured by the Griess reaction in supernatants, Because 
the toxin solution contains 0.15 mM sodium azide controls were carried out, using 
sodium azide. Results are representative of three separate experiments. The means 
± SEMs of triplicate cultures are shown. (n=3)
Figure 5.7.b: The effect of cholera toxin on glucose uptake of J774 cells were 
evaluated. Cells were adjusted to 1x10^ cells/well. Cells were treated with 2 pCi/ml 
pH]-glucose and in RPMI 1640 medium. Cells were treated with IFN-y (40 U/ml) 
and LPS (10 ng/ml) with and without Ctx (50 pg/ml) and untreated cells were used 
as controls, then the incubation was continued at 37®C for 24 hrs. After 24 hours, 
cells were counted for pH ] on a scintillation counter. Sodium azide treated wells 
were used as positive controls. The uptake of pH]-glucose was presented as CPM 
values for each group. Results are representative of three separate experiments. The 
means ± SDs are shown.
(*: p< 0.05, t- p< 0.1, n=3)
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Table 5.1: Choiera toxin induces a sustained intracellular elevation o f  
cAMP in J774 cells:
J774 cells were adjusted to Ix 10^ cells/ml in RPMI 1640 medium and incubated in 
24-well plates. Ctx was used at the concentration of 50 |iig/ml as final 
concentration. Cells were incubated at 37*^C for different time points (15 mins, 8 
and 24 hrs). Untreated cells were used as controls. Results are representative of 
three separate experiments. The means ± SDs are shown in triplicate samples. 
(n=3)
cAMP pmol/10 cells
Time Ctx treated cells Control cells
15 mins 44.33±1.15 0.167+0.275
8  hrs 20.70±2.30 4.330+1.53
24 hrs 6.00 ± 0.57 5.83 + 1.01
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5.2.9.a. Pertussis toxin does not alter NO production in J774 ce lls  
and CBA mouse peritoneal macrophages;
The role of pertussis toxin (Ptx) sensitive G-proteins was investigated with respect 
to NO production. J774 cells or peritoneal macrophages obtained from CBA mice 
treated with thioglycollate (ip) for 3-4 days, as detailed in Chapter 2, were used,
CBA peritoneal lavage in RPMI medium was centrifuged at 1000 RPM for 5 
minutes, and the pellet was washed three-times with sterile warm PBS. Cells were 1
resuspended in RPMI 1640 medium by using sterile plastic Pasteur pipettes. Cells 
were adjusted to 5 x 10 /ml in RPMI 1640 medium, were cultured in 96-well 
plates, then incubated at 37®C for 2 hours. Cell adhesion was examined by using a 
Zeiss microscope. Medium was changed to remove non-adherent and dead cells.
Ptx, dissolved in RPMI 1640 medium, was added one and half hours before 
stimulation with IFN-y and LPS.
N02~ levels were measured by the Griess reaction in supernatants, as detailed in 
Chapter 2. Ptx, at a variety of concentrations (10-500 ng), did not affect NO 
production induced by IFN-y (40 U/ml) and LPS (10 ng/ml) or LPS alone (1 
pg/ml) in CBA mice peritoneal macrophages and J774 cells. In control wells, Ptx in 
the absence of other stimuli did not induce NO production. (Figure 5.8 .a). Cell 
viability was examined by trypan blue exclusion and evaluated as normal in cells 
treated with Ptx.
5.2.9.b: Pertussis toxin does not alter NO production in response to 
LPS:
The effect of Ptx on NO production in response to LPS was studied to observe 
whether LPS at excessive concentrations might result in ineffective Ptx-mediated 
signalling, or whether there is no involvement of Ptx-sensitive proteins in signal
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transduction mechanisms leading to NO production in response to LPS. J774 cells 
or peritoneal macrophages obtained from CBA mice were used. Cells were adjusted 
to 5 X 10^ /ml in RPMI 1640 medium, were cultured in 96-well plates, then the 
effect of Ptx on NO production in response to LPS at a variety of concentrations by 
J774 cells were investigated. Ptx (100 ng/ml), dissolved in RPMI 1640 medium, 
was added one and half hours before stimulation with LPS. NO2 " levels were 
measured by chemiluminescence in supernatants. Ptx did not affect NO production 
induced by LPS in J774 cells. In control wells, Ptx in the absence of LPS did not 
induce NO production (Figure 5.8.b). Cell viability was examined by trypan blue 
exclusion and evaluated as noimal in cells treated with Ptx. Moreover, cells treated 
with Ptx were able to adhere and spread in a similar manner to untreated cells, and 
the general morphology appeared also normal. I
5.2.10. Pertussis toxin does not alter NO production in response to
IFN -y at a variety of concentrations and to a low concentration of 
LPS;
Finally, it is required to observe the effect of Ptx on NO produced by cells in 
response to IFN-y and LPS, using a wide range of concentration of IFN-y. 
Therefore, J774 cells were adjusted to 5 x 10^ /ml in RPMI 1640 medium, and 
cultured in 96-well plates, then the effect of Ptx on NO production in response to 
different doses of IFN-y at different concentrations, from 0.4 to 400 units, and to 
LPS (10 ng/ml) by J774 cells were investigated. Pertussis toxin (100 ng/ml), 
dissolved in RPMI 1640 medium, was added one and half hours before stimulation 
with LPS. NO2 ’ levels were measured by chemiluminescence in supernatants.
iPtx did not affect NO production induced by IFN-y at variety activity units and LPS 
in J774 cells. In control wells, Ptx in the absence of IFN-y and LPS did not induce 
NO production (Figure 5.9). Cell viability was examined by trypan blue exclusion 
and evaluated as normal in cells treated with Ptx (>95%).
I
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Figure 5.8.a; The effect of pertussis toxin on NO production in J774 cell lines 
and CBA murine peritoneal macrophages. J774 cells or peritoneal macrophages 
were cultured in 96-well plates. Pertussis toxin, over a wide range of 
concentrations (10-500 ng), was added one and half hours before stimulation with 
IFN-y (40 U/ml) and LPS (10 ng/ml) or LPS alone (1 pg/ml). NO2 " levels were 
measured by the Griess reaction in supernatants. Results are representative of 
three separate experiments. The means ± SEMs of triplicate cultures are shown. 
(n=3)
Figure 5.8.b; The effect of pertussis toxin on NO production in response to LPS 
at variety concentrations. J774 cells were cultured in 96-well plates. Pertussis toxin 
(100 ng/ml), was added one and half hours before stimulation with LPS at a variety 
of concentrations (1 0  ng -1 pg/m l). NO2 '  levels were m easured by 
chemiluminescence in supernatants. Results are representative of three separate 
experiments. The means ± SEMs of triplicate cultures are shown. (n=3)
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Figure 5.9: The effect of pertussis toxin on NO production in response to IFN-y 
at a variety of concentrations and LPS (10 ng/ml). J774 cells were cultured in 96- 
well plates, then the effect of Ptx (100 ng/ml), added one and half hours before 
stimulation with LPS, on NO production in response to IFN-y at a variety of 
concentrations (0.4-400 U/ml), and 10 ng/ml LPS by J774 cells were investigated. 
NO%" levels were measured by chemiluminescence in supernatants. Cell viability 
was examined by trypan blue exclusion and evaluated as normal in cells treated with 
Ptx. The means ± SEMs of triplicate cultures are shown. Results are representative 
of three separate experiments. (n=3)
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DISCUSSION:
It has previously been shown that the induction of NO production by IFN-y and 
LPS is dependent on PKC activation [Severn et al, 1992b]. It may have been 
possible that Ptx activates G-protein-associated phospholipase C (PLC), producing 
DAG which then activates PKC. Data presented in this chapter suggest that the Ptx 
sensitive-G-proteins, like Gpic, are not involved in the induction of NO in 
macrophages, and modification of G-proteins does not alter NO production in the 
J774 macrophage-like cell line. Therefore, it is clear that the signalling events 
leading to NO production are independent on G-protein-mediated effectors.
In Pertussis disease, there is a necrosis of the basal and midzonal portions of the 
bronchial epithelium and a marked inflammatory infiltrate which consists mainly of 
PNL [Ritchie, 1990]. This lesion may be caused by increased NO production 
which is produced by cells in the necrotic area, since the role of NO in epithelial 
autotoxicity in pertussis disease has also been reported [Heiss et al., 1994]. In the 
P388D1 macrophage like cell line, it has been reported that LPS induces G-protein 
activity, which can be blocked by Ptx [Jakway and De Franco, 1986].
PAF induces an elevation of intracellular cAMP levels, like PGE2  does. There is 
evidence showing that NO plays a protective role in the acute gastrointestinal 
damage induced by PAF [Boughton-Smith et al, 1992; MacKendrick et al, 1993]. 
However, data presented here also suggest that PAF does not alter NO production 
in J774 cells.
'I
I
NO production, stimulated by IFN-y and LPS, is not inhibited by Ctx, even 
although Ctx induces intracellular cAMP levels. A sustained increase in intracellular 
cAMP levels was induced by Ctx in J774 cells, at concentrations which inhibited 
NO production. However, it was not significant because of sodium azide found in
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the Ctx solution. We have shown that other agents which increase cAMP levels 
inhibit NO production (Buiut et al. 1993).
Glucocorticoids, dexamethasone, hydrocortisone and cortisol, inhibit the induction 
of iNOS, but not its activity, in response to LPS and IFN-y, in vitro in vascular 
endothelial cells [Radomski et al., 1990] and the J774 macrophage cell line [Di 
Rosa et al., 1990]. However, in this study, it was not found to be a robust finding, 
using a variety of concentrations of dexamethasone in J774 cells.
The role of PLA2 in activation of PKC has been reported, so that, Cis unsaturated 
fatty acids, including oleic, linoleic, linolenic, arachidonic and docosahexaenoic 
acids may be hydrolysed by PLA2, and the products can enhance PKC activity. In 
OK-432 (picibanil) treated peritoneal exudate macrophages, NO production was 
inhibited by the PLA2 inhibitors, dexamethasone and 4-BPB, the lipoxygenase 
inhibitor, nordihydroguaiaretic acid (NDGA). Nevertheless, caffeic acid and 
esculetin, inhibitors of 5- and 12-lipooxygenase respectively, were not inhibitory 
[Ryoyama et al., 1993]. Data demonstrated here suggest that PLA2 inhibitors are 
ineffective on NO production in response to IFN-y and LPS in the J774 cell-line.
I
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6. DISCUSSION:
Until the 1990s, it was accepted that the classical criteria for macrophage activation 
are la antigen (Immune response; IR; MHC class II) expression, the induction of 
reactive oxygen intermediate production and the ability to inhibit the proliferation of 
intracellular protozoa. Besides that the secretion of reactive nitrogen intermediates, 
such as NO, NO2 ", ONOO", is now considered as an additional criterion in 
macrophage activation [Nibbering et al., 1992].
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Nitric oxide produced by macrophages at high concentrations plays an important 
role in the regulation of T lymphocytes, although there is no clear evidence for B 
lymphocyte regulation. Recently, it was suggested that NO produced at 
physiological concentrations by constitutive NOS activity is required for 
proliferation of T cells. However, high concentrations of NO inhibit the 
proliferation of T cells and IFN-y secretion by Thl-like cells [reviewed by Liew,
1995]. The balance between Thl-like and Th2-like cells detennines the outcome of 
a number of infectious and autoimmune diseases [Liew, 1989; Sher and Coffman,
1992; Romagnani, 1991; Mason and Fowell, 1992; Bloom et al., 1992]. Their 
chamcteristic cytokines play important roles for these effects. For instance, Thl-like 
cells produce IFN-y which, together with other molecules such as LPS and TNFa, 
activates macrophages to produce NO which mediates cytopathic and microbicidal
effects [Nathan and Hibbs, 1991; Hibbs et al., 1990; Liew and Cox, 1991; Green
'et ah, 1990]. On the other hand, Th2-like cells produce IL-4 and IL-10 which 
inhibit the synthesis of NO by macrophages [Liew et al., 1991; Cunha et ah, 1992;
Gazzinelli et ah, 1992].
This is clearly an important area, as an understanding of this mechanism may lead 
to effective control of this important biological mediator, NO, and therapy for
several important diseases, such as parasitic diseases, rheumatoid arthritis, and 
tumours.
Data presented in this thesis contribute to the understanding of NO production and 
regulation mechanisms. These data suggest that cytokine signalling pathways inside 
macrophages are non-linear and form a network with cross-talk occurring among 
different signalling pathways. Therefore a ligand binding unit of the receptor may 
not be the sole determinant of the cellular responses. Accordingly, a single receptor 
may couple to multiple signal transduction systems, for example, IL-4 treatment of 
human B cells results in the hydrolysis of PIP2 , elevation of DAG and IP3 , as well 
as delayed cAMP production [Finney et al., 1990]. Likewise, multiple receptors 
may couple to the same signal transduction pathway via common transducers, for 
instance, both (3-adrenergic receptors and PGE2  induces cAMP generation by the 
activation of adenylyl cyclases.
It has been previously demonstrated that the activation of PKC is required for the 
induction of the macrophage iNOS gene transcription [Severn et al., 1992b]. In this 
study, IL-4 inhibits the synthesis of NO via the blocking of PKC activation. This is 
supported by our finding that transcription of the iNOS gene was inhibited by IL-4 
as well as the PKC inhibitor, Ro31-8220. It was demonstrated that PKC-epsilon 
(PKC-e) is the predominant isoform in the macrophage that translocates to the 
membrane when the cells are activated with IFN-y and LPS [Sands et al., 1994a]. 
It should be noted that IL-4 inhibits NO synthesis only when macrophages are 
pretreated with this cytokine before activation with IFN-y and LPS [Liew et al.,
1991]. Inhibition of PKC activation also required incubation with IL-4 for several 
hours before stimulation. IL-4 did not effect an immediate reduction in [^H]-PDBu 
binding to whole cells, and addition of IL-4 to the cells at the same time as or after 
IFN-y and LPS did not prevent the rise in pH]-PDBu binding [Sands et al., 
1994a]. Thus, the mechanism of the interaction of IL-4 and IFN-y in the control of
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NO synthesis is complex and factors other than PKC are probably involved. An 
earlier report has described inhibition of PKC by IL-4 in lymphocytes [Hart et al., 
1989b], but it is not yet clear how IL-4 inhibits PKC activation. It may inhibit 
generation of DAG, the physiological activators of PKC, [Nishizuka, 1992], by 
acting on a phospholipase. Meanwhile, There was no observed Ca^+ elevation and 
IP3 generation in macrophages induced by IFN-y and LPS [Sands et al., 1994b], 
and it was reported that phosphatidylcholine-specific PLC (PC-PLC) is involved in 
DAG generation and PKC activation induced by IFN-y and LPS in macrophages 
[Sands et a l ,  1994b]. The blocking of the PKC activation pathway by IL-4 may, 
therefore, explain its general inhibitory effects on macrophages. IL-4 induces a 
novel signal transduction cascade involving an immediate and transient elevation of 
inositol 1,4,5-triphosphate and Ca^+ levels, followed by a sustained rise in cellular 
cyclic AMP levels [Hart et al, 1992]. In human B cells, IL-4 does induce a delayed 
rise in cAMP [Finney et a l ,  1990]. Therefore, we have excluded an increase in 
intracellular cAMP concentration as a mechanism of inhibition of NO production by 
IL-4. This was not detected in J774 cells. However, differences between the 
signalling pathways of human and murine IL-4 have been reported [McGarvie and 
Cushley, 1989]. Additionally, other differences in iNOS regulation can be 
observed between different types of macrophage. For instance, IL-4 was reported 
to strongly reduce iNOS mRNA at late times post stimulation (24-72 hrs), but not 
at early times post stimulation (4-6 hrs after exposure to IFN-y and LPS) in primary 
peritoneal mouse macrophages [Bogdan e ta l ,  1994]. Figure 6 .1 shows a proposed 
pathway involved in the inhibition of NO production by IL-4 and cAMP elevation.
The roles of other kinases such as myosin light chain kinase or calmodulin- 
dependent kinase in tumoricidal activation appeared to be limited, since the 
inhibitors of these enzymes, ML-7 or W-7, failed to block LPS triggered 
macrophage activation [Novotney etal., 1991].
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IFN-y is the most potent known lymphokine for activating mononuclear phagocytes 
[Nathan et ah, 1984]. IFN-y results in eicosanoid production, such as PGE^, in 
macrophages [Uhing et ah, 1990], The receptor of murine IFN-y has been cloned 
and the specific phosphorylation site for PKA, Arg-Arg-Ser-Phe-Ser, between 351- 
357 amino acids has been identified [Gray etal., 1989]. Therefore, the effect of the 
intracellular cAMP elevation is required to explore NO production regulating 
mechanisms.
Data presented in this thesis demonstrate that NO production by m urine  
macrophages is inhibited by a prolonged increase in intracellular cAMP 
concentrations. It was reported that cyclic nucleotides are involved in the regulation 
of several macrophage functions, including phagocytosis, locomotion, responses to 
lymphokines, and DNA synthesis [Reviewed by Moncada et al., 1991]. The role of 
cAMP elevation and PKA activation is to produce or direct negative signals in the 
cells, whereas PKC directs positive signals [Reviewed by Nishizuka, 1986].
What could be the role of the cAMP pathway in the inhibition of NO production in 
macrophages? According to our PCR, SDS-Page and western blotting data, it is 
clear that the inhibitory effect of cAMP elevation on NO production is involved in 
post transcriptional or translational levels of the iNOS gene and iNOS protein 
synthesis, and not at the level of transcription.
Meanwhile, the use of IBMX, a nonspecific PDE inhibitor, which might inhibit the 
PLC enzyme as well, is questionable. However, the specific inhibitor of cAMP, 
Rp-cAMP, reversed the inhibitory effect of cAMP elevation on NO production. 
Since the cells can exhibit an IBMX-resistant cAMP phosphodiesterase activity, we 
also used rolipram, which is a specific cAMP-specific PDE inhibitor, to evaluate if 
there is a difference between the effects of IBMX and rolipram. There was no 
difference found between the use of IBMX and rolipram, suggesting that the use of
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IBMX is sufficient to observe the effect of cAMP-elevating agents on NO 
production in macrophages.
J774 macrophage NOS has a consensus sequence for PKA [Lowenstein et al., 
1992], and it may be that phosphorylation by this enzyme reduces the activity of 
NOS. Activated macrophages produce large quantities of PGE2  [Nathan, 1987], 
and this may contribute to the regulation of NO production, via the elevation of 
cAMP. On the other hand, PKA activity can cause phosphorylation of many other 
kinases, such as Raf kinases, and other proteins, involved in NO producing 
process in macrophages. It is clear that cAMP-dependent protein kinases (PKA) 
regulate the expression of numerous eukaryotic genes by agents such as epidermal 
growth factor and mobilised calcium [Sheng et al., 1988]. Intracellular cAMP 
elevation can block receptor-induced PKC activation [Takai, et al. 1982a]. PGE2 
may have a very important role in immune regulation. For instance, PGE2  inhibits 
IL-2  and IFN-y production from Thl clones, but not IL-4 and IL-5 production from 
Th2 clones [Betz and Fox, 1991]. It has been reported that human alveolar 
macrophages suppress the proliferation of peripheral blood lymphocytes via their 
secretory product PGE2  [McCombs et al., 1982]. Meanwhile, Kawabe and co­
workers [1992] reported that NO secreted by activated alveolar macrophages was a 
major suppressive agent in this system.
Finally, LPS treatment of macrophages results in the activation of various genes, 
including the genes for TNF-a, IL-1, IFN-p, NOS as well as the proto-oncogenes 
c-fos, c-jun, c-fms and c-myc. The activation of these genes is regulated at the 
transcriptional level by some DNA-binding transcriptional factors such as NF-kB
a:
or AP-1 [Lenardo and Baltimore, 1989]. It has been shown that LPS-treatment of 
J774 cells leads to the activation of the fast-moving (called B l) and slow- 
moving(called B2) NF-kB, and this activation is inhibited by H89, which is a 
PKA inhibitor, but not by a PKC inhibitor, H7 [Muroi and Suzuki, 1993].
3:
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Furthermore, the pretreatment of J774 cells with dibutyryl cAMP, forskolin, 
cholera toxin and IBMX induced NF-kB activation, and LPS treatment results in 
type 1 PKA activation in macrophages. The correlation between NF-kB activation 
and NO production in macrophages has not been clearly shown.
Data presented here also suggest that the Ptx sensitive-G-proteins are not involved 
in the induction of NO in macrophages, and modification of G-proteins does not 
alter NO production in J774 cells. It might be possible Ptx activates G-protein- 
associated phospholipase C (PLC), producing DAG which then activates PKC. The 
role of NO in epithelial autotoxicity in pertussis disease has also been reported 
[Heiss et al., 1994]. In the P388Di macrophage like cell line, it has been reported 
that LPS induces G-protein activity, which can be blocked by Ptx [Jakway and De 
Franco, 1986].
NO production, stimulated by IFN-y and LPS, is not inhibited by Ctx, even 
although Ctx induces elevated levels of intracellular cAMP. A sustained increase in 
intracellular cAMP levels was induced by Ctx in J774 cells, at concentrations which 
inhibited NO production. This difference might be dependent on multipotent effect 
of Ctx or cAMP elevation may be transient in response to Ctx, since PDEs are 
activated in response to high level cAMP levels and PKA activation [reviewed by 
Houslay, 1990].
Glucocorticoids, dexamethasone, hydrocortisone and cortisol, inhibit the induction 
of iNOS, but not its activity, in response to LPS and IFN-y, in vitro in vascular 
endothelial cells [Radomski et al., 1990] and the J774 macrophage cell line [Di 
Rosa et al., 1990]. However, in our study, it was not found to be a robust finding, 
using a range of concentrations of dexamethasone at different time points in J774 
cells. The inhibition of NO synthesis by glucocorticoids explains many therapeutic 
actions of these agents in antierythema, antiedema, endotoxin shock, asthma and
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rheumatoid arthritis, where NO may be responsible for pathological vasodilatation 
and tissue damage. Moreover, NO synthesis inhibition may help to explain why 
glucocorticoids cause the spread of infections [Schaffner and Schaffner, 1987] and 
malignancy [Schultz et al., 1985; Hogan and Vogel, 1988].
Platelet activating factor (PAF), which is a secretory product of activated 
macrophages, has a high affinity receptor on the surface of macrophages, and the 
binding of PAF to the receptor results in the rapid breakdown of 
polyphosphoinositides, di acyl glycerol production, and phosphorylation via protein 
kinase C [Rosen et al., 1989]. Moreover, PAF induces elevated levels of 
intracellular cAMP, like PGE2  does [Nibbering et al., 1992; Adams and Hamilton,
1992]. There is evidence showing that NO plays a protective role in the acute 
gastrointestinal damage induced by PAF [Boughton-Smith et al., 1992; 
MacKendrick et al., 1993]. Meanwhile, NO is involved in the process of neutrophil 
and platelet activation in the rabbit [May et al., 1991]. Therefore, an investigation of 
the effects of PAF on NO production in macrophages would be useful fo r 
understanding the mechanism, which is involved in the NO producing pathway. 
However, PAF was not found to affect NO production.
The role of PLA2  in activation of PKC has been reported, so that, Cis unsaturated 
fatty acids, including oleic, linoleic, linolenic, arachidonic and docosahexaenoic 
acids may be hydrolysed by PLA2 , and the products can enhance PKC activity. In 
OK-432 (picibanil) treated peritoneal exudate macrophages, NO production was 
inhibited by the PLA2  inhibitors, dexamethasone and 4-BPB, lipoxygenase 
inhibitor, nordihydroguaiaretic acid (NDGA). Nevertheless, caffeic acid and 
esculetin, inhibitors of 5- and 12-lipooxygenase respectively, were not inhibitory. 
The cyclooxygenase inhibitors, such as indomethacin and ibuprofen, have not been 
found to be inhibitors for NO production [Ryoyama et al., 1993]. Conversely, Data
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demonstrated here suggest that PLA2  inhibitors are ineffective on NO production in 
response to IFN-y and LPS in J774 cell line.
6.2. CONCLUSIONS:
In conclusion, we have further defined the role of PKC in the induction of NO 
production by murine macrophages, showing its activation to be essential for iNOS 
gene transcription. We have also partly elucidated the mechanism by which IL-4 
inhibits NO production. The inhibition of PKC activation by IL-4 may explain its 
other effects on macrophages.
The inhibitory effect of cAMP-elevating agents on NO production in macrophages 
stimulated by IFN-y and LPS can add some useful information to explain how
cAMP-elevating agents direct the negative signalling in macrophages.
Understanding of macrophages signal transduction is still far from complete. Future 
work will undoubtedly uncover more receptor kinases and phosphatases that are 
involved in macrophage activation.
phosphorylation products in iNOS synthesis and NO production by macrophages 
treated with IFN-y and LPS. Meanwhile, the injection of ras protein or G-protein 
«S subunit into permeabilized macrophages may be useful to study G-protein 
functions in downstream signalling in the NO synthesis pathway.
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In our study, it has also been shown that toxin sensitive-G-proteins and PLA2 
activation are not involved in NO production in J774 cells.
6.3. FUTURE WORK:
Further applications can be the investigation of the role of PKC and PKA
The role of IL-4 inhibiting the downstream signalling in IFN-y and LPS-mediated 
NO production in macrophages needs further studies. This includes exploring the 
role of tyrosine kinases and gene transcription regulators, such as signal- 
transducers and activators of transcription (STATs), NF-kB and CREB proteins. In 
B cells, IL-4-mediated regulation of gene expression is related to Janus family 
kinases Jakl and Jak3, which mediate tyrosine phosphorylation of STATs, such as 
IL-4 nuclear activated factor (IL-4 NAF) and signal-transducing factor of IL-4 
(STF-IL-4) [Keegan et al., 1994; Johnston et al., 1994; Witthuhn et al., 1994].
The investigation of PKC regulated signalling mechanisms related to NO 
production will also be useful for understanding the activation and suppression of 
macrophages. Autophosphorylation of PKC and decreased Ca^+ affinity of PKC 
through the autophosphorylation have been reported [Huang et al., 1986]. In 
intracellular downstream signalling, traffic can be directed by PKC phosphorylated 
substrates, such as myristoylated alanine rich C kinase substrate (MARCKS) 
proteins and NF-kB. MARCKS is an acidic protein, 87 kDa, synthesised an 
myristoylated in response to LPS induction [Aderem and Allen, 1992].
I
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